follow
review
base
note
use
teach
clinic
immunolog
veterinari
student
immun
diseas
dog
place
six
differ
categori
type
allerg
condit
type
ii
autoand
alloantibodi
diseas
type
iii
immun
complex
disord
type
iv
cellmedi
immun
diseas
type
v
condit
gammopathi
type
vi
immunodefici
disord
separ
discuss
transplant
immunolog
use
drug
regul
unwant
immun
respons
also
includ
elsevi
scienc
bv
right
reserv
tel
fax
see
front
matter
elsevi
scienc
bv
right
reserv
pii
immun
diseas
classifi
sever
differ
way
sake
follow
review
categor
accord
basic
pathogenesi
six
distinct
categori
construct
first
four
origin
describ
gel
coomb
type
reaction
coomb
gell
last
two
type
v
vi
ad
author
six
categori
includ
type
diseas
mediat
homocytotrop
antibodi
typifi
immediatetyp
hypersensit
ie
allergi
type
ii
diseas
mediat
autoor
alloreact
antibodi
type
iii
diseas
mediat
immun
complex
deposit
character
vascul
type
iv
diseas
mediat
cellmedi
immun
reaction
manifest
plasmacyticlymphocyt
infiltr
type
v
diseas
manifest
gammopathi
type
vi
diseas
manifest
immunodefici
opportunistictyp
infect
veterinari
immunolog
immunopatholog
classif
scheme
admittedli
oversimplif
proven
use
train
veterinari
student
modif
made
disord
system
lupu
erythematosu
sle
element
autoantibodi
immun
complex
reaction
immun
form
amyloidosi
also
clearli
fit
six
categori
includ
immun
complex
diseas
bear
immunopatholog
clinic
similar
must
stress
immun
diseas
due
distinct
patholog
type
immun
respons
rather
result
normal
type
immun
respons
occur
dysregul
fashion
excess
durat
abnorm
locat
antigen
normal
consid
foreign
type
allerg
diseas
associ
ige
system
one
primari
defens
parasit
attack
type
ii
autoand
alloantibodi
reaction
involv
format
antibodi
react
selfantigen
type
iii
reaction
involv
deposit
clearanc
immun
complex
essenti
featur
normal
immun
respons
type
iv
diseas
involv
cellular
immun
import
immun
defens
pathogen
pathogen
state
involv
cell
type
v
diseas
involv
excess
product
immunoglobulin
part
immunoglobulin
type
vi
diseas
occur
someth
imped
normal
immun
defens
mechan
either
innat
adapt
six
gener
factor
underli
immun
diseas
dog
foremost
genet
suscept
dog
purebr
purebreed
alway
involv
inbreed
great
divers
immun
mechan
henc
genet
complex
develop
regul
understand
inbreed
result
spectrum
disord
rang
dysregul
immun
system
autoimmun
one
extrem
cancer
although
may
oversimplist
suscept
autoimmun
diseas
thought
control
interplay
environment
herit
factor
latter
involv
gene
major
histocompat
complex
mhc
campbel
milner
gender
dog
second
common
cofactor
quimbi
et
al
intact
femal
highest
incid
immun
diseas
intact
male
lowest
observ
human
gender
bia
nearli
obviou
widespread
spay
castrat
ovariohysterectomi
reduc
incid
castrat
increas
incid
thu
tend
equal
gender
effect
neuter
anim
third
common
factor
underli
immun
diseas
presenc
immunolog
disord
certain
breed
bloodlin
dog
suffer
one
immun
diseas
also
increas
incid
wide
rang
immunolog
disord
demonstr
studi
old
english
sheepdog
day
penhal
plasmacyticlymphocyt
thyroid
hypothyroid
common
occurr
among
dog
develop
type
immun
diseas
dog
system
lupu
erythematosu
may
also
present
autoantibodi
associ
cytopenia
fourth
common
cofactor
infecti
diseas
infect
trigger
allergi
format
autoantibodi
adachi
et
al
immun
complex
diseas
cellmedi
patholog
gammopathi
immunodefici
fifth
common
factor
underli
immunolog
diseas
dog
drug
drug
includ
biolog
especi
given
dog
certain
genet
predisposit
trigger
varieti
immun
reaction
cribb
giger
et
al
grondalen
harvey
sixth
common
factor
associ
immun
diseas
cancer
day
b
c
cancer
frequent
aris
cell
immun
system
affect
immun
system
paraneoplast
effect
type
diseas
mediat
immediatetyp
hypersensit
respons
occur
one
target
tissu
immediatetyp
hypersensit
reaction
mediat
mainli
ige
lesser
extent
igg
antibodi
iga
igm
antibodi
occasion
involv
antibodi
particip
reaction
abil
sensit
cell
particular
mast
cell
basophil
sensit
process
wherebi
specif
cytotrop
antibodi
bind
cell
membran
bind
correspond
antigen
membran
bound
antibodi
molecul
trigger
allerg
reaction
cytotrop
antibodi
system
play
import
role
normal
immun
respons
particularli
parasit
somewhat
analog
secretori
iga
igm
antibodi
system
local
area
bodi
parasit
apt
gain
access
travers
ie
skin
mucou
membran
gi
respiratori
tract
bloodstream
around
blood
vessel
portomesenter
system
benefici
natur
respons
import
keep
mind
mani
peopl
believ
cytotrop
antibodi
immediatetyp
hypersensit
reaction
nuisanc
valu
antibodi
particip
type
reaction
either
homoor
hetrocytotrop
homocytotrop
antibodi
sensit
anim
speci
speci
homocytotrop
antibodi
usual
ige
class
anim
test
heterocytotrop
antibodi
usual
igg
igm
iga
class
sensit
cell
speci
well
cytotrop
antibodi
extrem
high
avid
receptor
membran
mast
cell
within
h
format
bind
fc
portion
mast
cell
igg
iga
igm
cytotrop
antibodi
short
life
span
mast
cell
membran
h
ige
antibodi
remain
strongli
attach
three
six
week
cytotrop
antibodi
produc
lymphoid
tissu
underli
mucou
membran
bodi
peyer
patch
tonsil
diffus
lymphoid
aggreg
antigen
elicit
specif
cytotrop
antibodi
respons
call
allergen
marsh
norman
allergen
gener
molecular
weight
restrict
da
substanc
da
suffici
larg
bridg
two
adjac
membran
bound
molecul
cytotrop
antibodi
larger
allergen
penetr
mucou
membran
allergen
highli
polar
substanc
contain
mani
sulfhydryl
group
sensit
nanogram
microgram
amount
besid
size
chemic
makeup
allergen
elicit
ige
respons
often
taken
host
low
dosag
across
mucos
surfac
marsh
norman
allergen
part
parasit
hous
dust
mite
cockroach
condit
allow
excess
buildup
insect
environ
also
increas
exposur
level
allergen
mani
allergen
resembl
proteinac
substanc
cuticl
parasit
eg
pollen
mold
spore
dander
drug
cosmet
substanc
cigarett
smoke
may
also
act
allergen
target
cell
allerg
reaction
tissu
mast
cell
circul
basophil
approxim
mast
cell
per
ml
skin
intestin
tissu
mast
cell
basophil
possess
cytoplasm
granul
contain
potent
inflammatori
mediat
anticoagul
heparin
histamin
serotonin
kinin
proteas
slow
react
substanc
anaphylaxi
srsa
also
contain
substanc
repar
function
chymas
hyaluron
acid
platelet
aggreg
factor
well
eosinophil
neutrophil
chemotact
factor
sraa
singl
compound
mixtur
spasmogen
vasodilatori
metabolit
arachidon
acid
call
leukotrien
sraa
also
sole
product
mast
cell
contribut
mast
cell
activ
tissu
mononuclear
cell
basophil
probabl
circul
form
mast
cell
although
differ
respons
certain
substanc
cromolyn
sodium
inhibit
releas
mast
cell
granul
basophil
granul
releas
mast
cell
basophil
granular
content
trigger
bind
allergen
specif
cytotrop
antibodi
cell
surfac
bind
one
molecul
allergen
two
adjac
molecul
specif
cytotrop
antibodi
alter
cell
membran
initi
energi
depend
process
culmin
releas
pharmacolog
mediat
allerg
respons
given
individu
degre
sensit
directli
proport
amount
histamin
releas
mast
cell
circul
basophil
respons
standard
amount
particular
allergen
ige
system
strong
tcell
regul
romagnani
invers
relationship
cellular
ige
immun
ige
product
enhanc
thymectomi
subleth
whole
bodi
irradi
antithymocyt
serum
radiomimet
drug
certain
viral
infect
individu
congenit
acquir
immunodefici
syndrom
involv
cellular
immun
syndrom
hodgkin
diseas
phenomenon
allerg
breakthrough
occur
great
clinic
relev
ige
product
minim
normal
nonallerg
individu
kept
way
intern
regulatori
mechan
involv
tlymphocyt
romagnani
natur
event
viral
infect
temporarili
depress
tcellmedi
immun
thu
normal
dampen
mechan
remov
enhanc
ige
product
occur
genet
predispos
dog
develop
higher
level
specif
ige
expos
pollen
extract
sever
day
follow
canin
distemp
immun
frick
brook
enhanc
product
cytotrop
antibodi
nonparasit
antigen
may
also
result
disus
normal
ige
mediat
immun
heavili
parasit
peopl
may
less
problem
nuisanc
type
allergi
buckley
et
al
indic
ige
immun
system
engag
normal
parasit
defens
less
like
react
peripher
relat
antigen
develop
allergi
also
influenc
genet
huang
marsh
parent
atopi
children
atop
one
parent
atopi
chanc
similar
genet
predisposit
seen
anim
especi
among
purebr
anaphylaxi
classifi
system
anaphylact
shock
angioedema
hive
local
gi
skin
respiratori
allergi
system
anaphylact
reaction
trigger
allergen
enter
bloodstream
react
specif
sensit
mast
cell
target
organ
system
reaction
type
provok
dog
routin
vaccin
drug
phillip
et
al
foreign
protein
inject
insect
bite
food
stuff
pollen
mold
spite
widespread
belief
anaphylact
reaction
often
escal
sever
repeat
sensit
sever
anaphylact
reaction
occur
without
known
previou
exposur
much
like
manifest
similarli
follow
repeat
elicit
escal
sever
anaphylact
shock
anaphylact
shock
sever
form
system
anaphylaxi
target
organ
dog
tend
portomesenter
system
unlik
human
smooth
muscl
lung
either
spare
mildli
involv
local
releas
vasoact
amin
result
portomesenter
splanchnic
vasodilat
venou
pool
blood
peripher
vasocollaps
sever
case
death
clinic
sign
includ
nausea
vomit
diarrhea
ataxia
cold
pallor
mucou
membran
rapid
breath
case
bronchial
constrict
asthmat
type
breath
death
may
occur
short
min
anim
live
min
may
also
show
sign
hypersaliv
tenesmu
defec
profus
saliv
may
seen
min
angioneurot
edema
angioneuroticor
facioconjunctivaledema
less
sever
system
allerg
reaction
manifest
swell
lip
eyelid
conjunctiva
occasion
associ
mild
bronchial
constrict
gi
sign
mild
shock
edema
reach
peak
min
may
take
sever
hour
subsid
type
reaction
evok
sort
allergen
system
anaphylact
reaction
urticaria
urticari
reaction
hive
coinlik
sharpli
delin
highli
prurit
lesion
skin
occur
within
minut
allergen
exposur
analog
lesion
evok
intraderm
inocul
histamin
hive
may
sole
manifest
allerg
reaction
may
associ
reaction
clinic
sign
gener
last
h
subsid
dog
manifest
anaphylact
reaction
provoc
test
iv
im
subcutan
inject
suspect
allergen
someth
potenti
danger
usual
done
fortun
diagnosi
usual
made
detail
histori
effect
control
system
allerg
reaction
avoid
reexposur
offend
allergen
easili
done
drug
offend
altern
product
usual
avail
allergen
howev
vaccin
common
caus
reaction
problemat
veterinarian
mani
veterinarian
believ
booster
vaccin
absolut
essenti
unwil
forego
use
even
previous
evok
allerg
reaction
system
allerg
reaction
vaccin
lifethreaten
ie
anaphylact
shock
risk
subsequ
immun
far
outweigh
neglig
benefit
provid
booster
vaccin
chanc
older
wellvaccin
dog
get
potenti
fatal
infect
like
canin
distemp
infecti
canin
hepat
parvoviru
enter
leptospirosi
rabi
extrem
low
vaccinat
diseas
kennel
cough
parinfluenza
lyme
borreliosi
coronaviru
enter
limit
clinic
relev
gener
dog
popul
even
concern
legal
requir
rabi
booster
overrid
common
sens
waiver
usual
obtain
rabi
vaccin
use
vaccin
life
threaten
system
allerg
reaction
vaccin
sever
life
threaten
hive
angioneurot
edema
pretreat
anim
h
immun
antihistamin
prednisolon
give
vaccin
dose
advers
reaction
seen
min
administ
remaind
chang
brand
type
vaccin
seldom
prevent
problem
vaccin
contain
similar
offend
allergen
howev
leptospirosi
bacterin
worst
offend
least
essenti
vaccin
easili
left
vaccin
regimen
local
allerg
reaction
specif
organ
system
allerg
respiratori
diseas
allerg
rhiniti
vasomotor
rhiniti
common
allerg
disord
peopl
infrequ
dog
inhal
allergen
dog
commonli
associ
atop
dermat
rhiniti
opposit
true
peopl
might
reflect
differ
distribut
sensit
mast
cell
two
speci
caus
inhal
pollen
dander
dust
mold
cosmet
cigarett
smoke
miscellan
inhal
clinic
sign
may
season
case
season
allergen
year
around
sneez
snuffl
revers
sneez
common
present
clinic
sign
allerg
rhiniti
sign
usual
season
last
week
allerg
period
clinic
sign
usual
intermitt
rather
persist
nasal
discharg
scant
usual
serou
natur
sever
case
howev
sneez
nasal
discharg
pronounc
conjunct
redden
eye
serou
ocular
discharg
uncommon
accompani
featur
make
diagnosi
allerg
rhiniti
dog
import
rule
caus
chronic
rhiniti
nasal
mite
undetect
present
ident
manner
inde
dog
becom
allerg
nasal
mite
show
clinic
sign
infest
nasal
aspergillosi
may
present
sneez
neoplasia
nasal
passag
rel
common
older
dog
may
present
initi
sneez
foreign
bodi
especi
grass
awn
occur
dog
cat
associ
violent
sneez
initi
stage
purul
unilater
nasal
discharg
later
stage
complet
blood
count
routin
laboratori
test
usual
normal
dog
allerg
rhiniti
intraderm
allergen
test
variabl
benefit
determin
either
allerg
natur
rhiniti
specif
allergen
allergen
involv
diagnosi
usual
made
rule
caus
find
eosinophil
nasal
wash
respons
hospit
chang
environ
respons
glucocorticoid
therapi
may
also
help
prefer
treatment
allerg
rhiniti
find
caus
allergi
remov
allergen
environ
possibl
treat
glucocorticoid
use
everyotherday
mainten
therapi
lowest
effect
dose
limit
treatment
period
diseas
sign
present
allerg
bronchiti
common
allerg
condit
respiratori
tract
dog
presum
due
inhal
type
substanc
associ
allerg
rhiniti
clinic
sign
usual
chronic
year
around
manifest
chronic
dri
honkingtyp
cough
cough
easili
elicit
upon
tracheal
compress
often
evok
exercis
drink
water
excit
pull
leash
cough
usual
nonproduct
occur
paroxysm
end
gag
retch
follow
allerg
stimul
tracheal
bronchial
mucosa
mucos
cell
secret
thick
tenaci
type
mucu
mucu
though
copiou
thick
tenaci
difficult
anim
clear
characterist
cough
due
low
grade
irrit
anim
attempt
clear
mucu
airway
essenti
differenti
disord
caus
chronic
bronchiti
toy
breed
especi
poodl
collaps
trachea
syndrom
produc
sign
complic
matter
allerg
bronchiti
collaps
trachea
syndrom
may
coexist
inabl
dog
collaps
trachea
clear
foreign
matter
airway
may
predispos
develop
allergi
tracheobronchi
tree
chronic
bronchiti
due
low
grade
bacteri
infect
common
older
dog
especi
larger
sport
breed
probabl
associ
degener
local
mucocillari
activ
bronchial
mucosa
lung
worm
foreign
bodi
primari
lung
tumor
congest
heart
failur
disord
associ
tracheal
compress
also
rule
kennel
cough
due
variou
infecti
agent
particular
bordetella
bronchiseptica
also
import
differenti
diagnosi
diagnosi
allerg
bronchiti
fairli
easi
make
caus
chronic
bronchiti
usual
elimin
histori
physic
exam
chest
radiograph
caus
elimin
diagnosi
confirm
analysi
tracheal
wash
tracheal
wash
usual
bacteri
steril
contain
numer
eosinophil
cbc
normal
occasion
show
mild
eosinophilia
chest
radiograph
may
normal
show
mild
increas
bronchial
mark
difficult
find
caus
allergi
avoid
exposur
condit
usual
treat
expectorantbronchi
dilat
drug
theophylin
elixir
either
potassium
iodid
glycerol
guiachol
glucocorticoid
mild
case
respond
well
expectorantbronchi
dilat
alon
low
dose
glucococorticoid
therapi
eosinophil
pneumon
rel
common
dog
resembl
human
diseas
refer
acut
eosinophil
pneumonia
popeharman
et
al
pulmonari
eosinophilia
bain
flower
pulmonari
infiltr
eosinophilia
pie
pulmonari
eosinophilia
divers
group
disord
peopl
character
pulmonari
infiltr
rich
eosinophil
peripher
eosinophilia
known
caus
includ
fungi
especi
asperigilla
fumigatu
parasit
toxin
drug
caus
dog
similar
least
twofold
hypersensit
reaction
associ
inhal
allergen
particular
mold
use
certain
drug
b
parasit
migrat
occult
dirofilariasi
lung
worm
ascariasi
young
anim
idiopath
form
pulmonari
eosinophilia
human
includ
loffler
syndrom
acut
chronic
eosinophil
pneumonia
hypereosinophil
syndrom
bronchochentr
granulomatosi
pulmonari
eosinophilia
associ
vascul
bain
flower
idiopath
form
also
occur
dog
uncommon
clinic
sign
eosinophil
pneumon
dog
includ
fatigu
exercis
intoler
soft
cough
dyspnea
chronic
pulmonari
associ
weight
loss
chest
radiograph
show
diffus
interstiti
pulmonari
infiltr
around
alveoli
bronchiol
numer
eosinophil
tracheal
wash
blood
import
rule
parasit
infect
occasion
possibl
associ
diseas
environment
allergen
case
best
put
anim
new
environ
alter
exist
environ
elimin
exposur
case
howev
caus
unknown
environ
control
feasibl
glucocorticoid
sever
week
caus
rapid
resolut
radiograph
clinic
sign
diseas
often
reoccur
follow
treatment
pulmonari
granuloma
eosinophilia
uncommon
dog
caus
multifactori
probabl
involv
either
florid
reaction
pulmonari
parenchyma
dead
die
parasit
especi
dirofilaria
idiopath
hypersensit
angiiti
clinic
sign
includ
soft
cough
dyspnea
fatigu
exercis
intoler
larg
multipl
smaller
circumscrib
mass
lung
radiograph
pronounc
eosinophilia
tracheal
wash
blood
vascularli
orient
granulomat
reaction
intens
tissu
eosinophilia
usual
seen
biopsi
case
dirofilaria
dead
die
adult
worm
might
seen
lesion
glucocorticoid
effect
shrink
mass
improv
pulmonari
function
intestin
allergi
dog
intrins
food
intoler
extrins
allerg
origin
roudebush
although
trigger
mechan
differ
extrins
intrins
gastriti
form
ultim
mediat
basophil
degranul
vasoact
substanc
clinic
sign
virtual
ident
treatment
similar
acut
allerg
gastrit
manifest
vomit
food
within
min
less
eat
allerg
reaction
upper
small
intestin
apt
manifest
vomit
bile
ting
mucu
min
eat
vomit
may
period
time
per
week
constant
sever
time
day
weight
loss
poor
hair
coat
observ
sever
case
food
allergi
intoler
affect
small
intestin
also
common
dog
manifest
intermitt
chronic
diarrhea
associ
ingest
certain
food
bowel
movement
usual
normal
frequenc
amount
often
loos
wateri
foul
smell
dog
appear
otherwis
normal
although
sever
case
anim
may
thinner
normal
hair
coat
dri
poor
qualiti
eosinophilia
variabl
featur
even
present
seldom
pronounc
eosinophil
enter
sever
less
common
form
intestin
allergi
diarrhea
sever
dog
allerg
enter
system
sign
illhealth
promin
eosinophilia
strike
find
allerg
coliti
describ
dog
paterson
stool
normal
mucousladen
soft
frequenc
defec
often
increas
weight
loss
problem
anim
sever
coliti
import
dog
rule
caus
coliti
eg
whipworm
idiopath
coliti
boxer
coliti
spastic
coliti
mucou
coliti
lymphosarcoma
etc
dietari
allergi
intoler
common
dog
justifi
tri
special
diet
undertak
elabor
clinic
workup
diarrhea
particularli
sever
fecal
blood
loss
form
melena
red
blood
present
weight
loss
pronounc
system
sign
present
anim
hypoproteinem
initi
diagnost
workup
complet
specif
test
diagnos
food
allergi
intoler
allergen
test
food
allergi
extens
studi
man
serum
histamin
level
increas
sever
hour
feed
allergen
food
mild
eosinophilia
absenc
parasit
may
addit
clue
ermel
et
al
abl
evok
allerg
reaction
directli
mucosa
stomach
gastroscopi
although
clinic
applic
diagnosi
allerg
enter
ultim
made
show
respons
hypoallergen
diet
ingredi
hypoallergen
diet
dog
consist
food
normal
found
commerci
diet
cottag
chees
andor
tofu
rice
good
start
hypoallergen
diet
dog
fish
potato
altern
hypoallergen
diet
paterson
dog
allergicintoler
milk
protein
cottag
chees
rice
may
alway
appropri
improv
first
diet
tri
altern
diet
anoth
two
week
still
improv
forget
food
allergi
intoler
search
caus
dramat
improv
add
multivitamin
miner
supplement
diet
continu
feed
sever
week
time
new
food
introduc
one
time
everi
two
week
condit
sever
dietari
control
incomplet
imposs
prednisolon
effect
altern
treatment
allerg
skin
diseas
atop
dermat
preval
dog
initi
attribut
allergen
either
inhal
directli
contact
skin
pollen
mold
dander
hous
dust
insect
bite
flea
role
dietari
allergen
caus
atop
dermat
dog
recent
given
greater
emphasi
ermel
et
al
jeffer
et
al
paterson
breed
predisposit
especi
smaller
terrier
eg
cairn
west
highland
white
golden
retriev
labrador
retriev
dalmatian
clinic
sign
includ
prurit
lesion
face
feet
axilla
often
associ
selfmutil
intraderm
allergen
test
effect
anim
show
skin
manifest
associ
inhal
allergen
dietari
allergen
usual
identifi
use
eliminationprovoc
diet
jeffer
et
al
dog
fed
foodelimin
diet
clinic
sign
disappear
challeng
origin
diet
singl
major
compon
origin
diet
eg
beef
chicken
egg
milk
wheat
soy
corn
assay
detect
allergen
specif
ige
serum
increasingli
use
diagnos
allergen
dog
treatment
direct
whenev
possibl
avoid
offend
allergen
desensit
use
small
dosag
allergen
inject
parenter
use
dog
main
treatment
still
glucocorticoid
eosinophil
enceph
dog
rang
puppi
adult
present
sign
diffus
multifoc
meningoenceph
demonstr
high
number
eosinophil
cerebr
spinal
fluid
smithmaxi
et
al
anim
parasit
infect
brain
postmortem
mani
other
demonstr
obviou
caus
type
ii
reaction
character
develop
antibodi
react
cell
cellular
constitu
term
cytotox
origin
ascrib
categori
immun
diseas
gel
coomb
complet
correct
autoantibodi
direct
cell
surfac
also
cell
receptor
basement
membran
basal
lamina
intracellular
cement
substanc
format
selfreact
antibodi
involv
eight
basic
mechan
anomali
normal
immunoregul
ie
abnorm
selfnonselfrecognit
alloimmun
unmask
hidden
sequest
antigen
immunoglobulin
focus
crossreact
antibodi
innoc
bystand
effect
nonspecif
immunoglobulin
focus
product
autoantibodi
cancer
preb
bcell
although
thymu
play
import
role
elimin
clone
lymphoid
cell
react
selfantigen
earli
fetal
develop
evid
mani
individu
retain
capac
react
humor
cellular
manner
rang
selfantigen
said
autoantigen
abund
induc
clonal
delet
anergi
rare
escap
recognit
entir
janeway
traver
corato
et
al
conclud
normal
dog
autoerythrocyt
reactiv
lymphocyt
lymphocyt
must
prime
individu
aiha
herit
suscept
diseas
therefor
capac
gener
selfreact
immun
appear
suppress
normal
immun
system
tcell
system
particularli
involv
downregul
autoantibodi
product
bcell
antibodi
particular
selfantigen
gener
aspect
tcell
regul
must
fail
normal
tcell
regulatori
function
influenc
number
condit
includ
microbi
especi
viral
infect
vaccin
mcanulti
rudd
diseas
lymphoreticular
system
lymphosarcoma
certain
drug
genet
weak
result
instabl
selfnonselfrecognit
unrecogn
factor
alloantibodi
format
second
way
selfreact
antibodi
produc
usual
appli
immun
mother
patern
inherit
antigen
fetu
particular
rbc
antigen
sensit
mother
occur
pregnanc
fetal
blood
leak
matern
circul
time
parturit
attach
break
mother
immun
red
cell
antigen
common
fetu
cytotox
antibodi
pass
fetu
colostrum
condit
known
neonat
isoerythrolysi
occur
sensit
allogen
rbc
also
occur
result
prior
blood
transfus
dog
differ
rbc
type
lymphoid
cell
program
react
deepli
sequest
ie
hidden
antigen
may
escap
destruct
fetal
develop
immun
system
inde
mani
bodi
protein
antigen
recogn
sequest
host
immun
system
streilein
also
evid
natur
autoantibodi
exist
deepli
sequest
red
cell
membran
protein
eg
spectrin
dog
barker
elson
barker
et
al
antibodi
may
help
destruct
age
worn
red
cell
thyroglobulin
immunogen
inject
area
bodi
antithyroglobulin
antibodi
often
secondarili
associ
primari
destruct
diseas
thyroid
gland
dog
human
follow
myocardi
infarct
hepat
necrosi
human
antibodi
cardiac
muscl
microsom
cellular
constitu
appear
transient
serum
antinuclear
antibodi
ana
often
appear
serum
dog
aural
hematoma
antibodi
probabl
result
form
extravas
destruct
blood
cell
thu
releas
sequest
nuclear
antigen
ear
tissu
exampl
autoantibodi
may
marker
diseas
hypothyroid
dog
clinic
signific
autoantibodi
react
antigen
sequest
deep
within
cell
case
howev
autoantibodi
gener
manner
may
actual
pathogen
effect
brucella
cani
infect
often
local
testicl
dog
induc
autoantibodi
reaction
sperm
infertil
georg
carmichael
serikawa
et
al
immunoglobulin
focus
occur
certain
antigen
array
surfac
cell
case
certain
bacteri
protozo
rickettsi
viral
diseas
antigen
microorgan
incorpor
cell
surfac
host
cell
render
cell
membran
foreign
exact
natur
anemia
infect
alway
straightforward
erythrophagocytosi
promin
featur
babesia
gibsoni
infect
wozniak
et
al
although
hemolyt
activ
present
serum
appear
anemia
immun
mediat
classic
sens
onishi
et
al
drug
may
also
combin
cellular
protein
thu
creat
new
antigen
render
cell
surfac
target
host
immun
antigen
present
microorgan
may
elicit
antibodi
cross
react
normal
cellular
constitu
classic
exampl
human
cross
reaction
certain
streptococc
antigen
selfantigen
heart
valv
innoc
bystand
reaction
occur
circul
immun
complex
adsorb
unto
rbc
wbc
platelet
coat
cell
clear
phagocyt
system
nonspecif
immunoglobulin
bind
somewhat
similar
reaction
drug
particular
cephalosporin
damag
rbc
membran
allow
nonspecif
adher
immunoglobulin
complement
lymphoid
plasma
cell
tumor
sometim
produc
monoclon
autoantibodi
react
selfantigen
although
situat
admittedli
rare
likelihood
malign
bcell
produc
antibodi
reactiv
self
rather
nonselfantigen
low
likelihood
autoantibodi
pathogen
would
reduc
odd
german
shepherd
dog
malign
myeloma
polyneuropathi
may
incid
villier
dobson
immunemedi
hemolyt
anemia
iha
iha
occur
primari
idiopath
secondari
form
idiopath
iha
associ
known
exist
caus
secondari
iha
usual
associ
infecti
diseas
drug
neoplasia
man
cat
twothird
case
iha
itp
secondari
natur
howev
case
iha
dog
idiopath
studi
dog
iha
three
subsequ
manifest
underli
disord
one
dog
develop
sle
one
gener
lymphoma
one
unidentifi
thromboembol
disord
day
day
b
c
autoantibodi
usual
produc
erythrocyt
membran
antigen
precipit
studi
dog
antigen
either
cell
surfac
associ
glycophorinlik
peptid
kda
unknown
peptid
kda
phospholipid
protein
involv
erythrocyt
cytoskeleton
barker
et
al
iha
classifi
two
way
human
medicin
much
known
divers
caus
disord
classif
follow
immunemedi
hemolyt
anemia
although
type
classif
also
appli
veterinari
medicin
tendenc
lump
immunemedi
hemolyt
anemia
singl
group
unfortun
one
studi
case
coomb
agglutin
posit
hemolyt
diseas
dog
wide
spectrum
condit
evid
klag
et
al
threefourth
dog
coomb
antibodi
posit
usual
igg
without
complement
sphereocytosi
observ
twothird
hemoglobinemia
hemoglobinuria
onethird
moder
sever
reticulocytosi
mild
reticulocytosi
onethird
nonrespons
anemia
time
diagnosi
concomit
thrombocytopenia
seen
twothird
dog
mortal
also
vari
greatli
die
hospit
risk
death
significantli
increas
anim
without
mark
reticulocytosi
lower
pcv
greatest
elev
serum
bilirubin
obviou
find
number
differ
form
iha
therefor
prefer
stage
knowledg
classifi
iha
anim
clinic
term
eg
peracuteacut
subacut
chronic
must
recogn
howev
within
clinic
group
case
secondari
idiopath
drug
induc
either
warm
cold
agglutinin
may
involv
peracut
iha
peracut
iha
occur
commonli
larger
dog
shepherd
type
anim
year
age
form
iha
probabl
repres
subgroup
dog
describ
klag
et
al
highest
mortal
associ
nonrespons
anemia
lowest
pcv
highest
serum
bilirubin
level
etiolog
diseas
unknown
event
perhap
subclin
viral
bacteri
infect
trigger
rapid
develop
hightit
broadli
reactiv
hemagglutinin
similar
nonimmun
type
peracut
hemolyt
anemia
observ
rare
dog
commonli
cat
overwhelm
gramneg
bacteri
sepsi
serum
hemagglutinin
peracut
iha
often
react
red
cell
virtual
canin
donor
commonli
cross
speci
line
agglutin
human
cow
cat
goat
sheep
hors
cell
disord
precis
human
counterpart
aspect
canin
diseas
resembl
microangiopathictyp
hemolyt
disord
man
dog
peracut
iha
often
manifest
malais
lethargi
sometim
fever
day
prior
actual
hemolyt
episod
time
hospit
dog
obvious
depress
pcv
rang
slightli
depress
hemoglobinuria
port
wine
urin
observ
less
anim
pack
cell
volum
usual
drop
level
within
h
time
admiss
urin
serum
often
becom
increasingli
icter
appear
thromboembol
phenomena
frequent
accompani
peracut
anemia
may
clinic
manifest
neurolog
vestibular
abnorm
blind
dementia
cardiopulmonari
respiratori
distress
arrhythmia
renal
sign
elev
bun
characterist
featur
disord
presenc
intub
insalin
red
cell
agglutin
sever
nonrespons
anemia
time
initi
hospit
variabl
thrombocytopenia
neg
direct
coomb
test
igm
igg
laboratori
evid
dic
variabl
elev
fdp
decreas
antithrombin
three
level
consumptivetyp
thrombocytopenia
spontan
agglutin
rbc
disappear
blood
dilut
salin
henc
term
insalin
agglutin
insalin
agglutinin
extrem
difficult
case
find
compat
blood
due
high
titer
broadli
crossreact
agglutinin
small
proport
anim
similar
sign
septic
blood
cultur
routin
part
clinic
workup
affect
dog
immedi
heparin
aspirin
treat
dic
associ
microangioipath
anemia
thrombocytopenia
thromboembol
phenomena
product
insalin
agglutinin
halt
immedi
glucocorticoid
cyclophosphamid
therapi
incompat
transfus
avoid
possibl
becom
necessari
transfus
util
least
incompat
blood
make
sure
dog
fulli
heparin
prior
transfus
give
blood
slowli
sever
hour
untoward
transfus
sign
notic
ie
hemoglobinemia
hemoglobinuria
facial
edema
cardiac
problem
immedi
discontinu
transfus
give
incompat
blood
nonheparin
dog
counterind
greatli
enhanc
dic
thromboembol
phenomena
microangiopath
red
cell
destruct
dog
toler
pcv
provid
rest
comfort
heart
function
normal
gradual
improv
occur
begin
h
treatment
start
first
manifest
improv
outward
demeanor
anim
stabil
pcv
pcv
rise
slowli
level
next
week
platelet
count
return
normal
autoagglutin
subsid
full
restor
pcv
take
month
heparin
usual
continu
day
aspirin
therapi
sever
month
cyclophosphamid
week
glucocorticoid
sever
month
discontinu
recov
dog
usual
recurr
bout
diseas
unlik
form
aiha
prognosi
peracut
diseas
consid
poor
treat
aggress
almost
anim
die
mortal
associ
even
optim
treatment
whether
prognosi
grave
poor
somewhat
depend
follow
neg
prognost
factor
hemoglobinuria
compat
donor
sever
thromboembol
sign
also
dog
surviv
first
three
day
optim
treatment
prognosi
becom
favor
therapi
take
sever
day
take
effect
bone
marrow
anim
usual
enough
time
respond
time
pcv
reach
lowest
point
marrow
take
week
begin
respond
acut
blood
loss
subacut
iha
subacut
iha
classic
textbook
form
diseas
dog
ie
coomb
posit
respons
anemia
spherocytosi
day
day
b
c
subacut
iha
account
twothird
hemolyt
anemia
speci
occur
much
often
purebr
mongrel
disproportion
cocker
spaniel
compar
breed
clinic
sign
occur
period
day
usual
level
rbc
bound
antibodi
complement
reach
suffici
densiti
spleen
remov
circul
intravascular
hemolysi
uncommon
owner
usual
awar
clinic
problem
hematocrit
decreas
mean
day
b
c
point
lethargi
fatigu
exercis
pallor
tachypnea
manifest
affect
anim
may
show
gener
lymphadenopathi
pallor
mucou
membran
hepatosplenomegali
upon
physic
examin
icteru
bilirubinuria
seen
case
anemia
subacut
iha
respons
increas
mcv
reticulocytosi
polychromasia
spherocyt
usual
evid
blood
smear
spherocyt
damag
rbc
imbib
fluid
becom
spheric
rather
discshap
wbc
count
often
elev
occasion
left
shift
metamyelocyt
flamboy
leukocyt
respons
slopov
intens
erythropoiesi
may
mistaken
granulocyt
leukemia
case
order
preval
coomb
reactiv
usual
associ
igg
igg
igm
igm
autoantibodi
day
b
c
coomb
antibodi
warmreact
case
cold
agglutinin
present
igm
class
detect
autoantibodi
dog
subacut
iha
associ
glycophorin
similar
found
human
rhesu
complex
unknown
surfac
peptid
possibl
membran
associ
phospholipid
barker
et
al
barker
elson
dog
subacut
iha
immedi
danger
initi
treatment
usual
prednison
alon
day
b
c
initi
dosag
mgkg
small
dog
cat
mgkg
mediums
dog
mgkg
larg
dog
dose
often
divid
twice
daili
first
day
hematocrit
stabil
within
seven
day
start
rise
day
remiss
good
respond
usual
achiev
within
one
month
day
b
c
poor
respons
week
treatment
sever
weekli
cycl
cyclophosphamid
mgm
per
os
daili
four
consecut
day
week
ad
treatment
regimen
dose
prednison
taper
mgkg
week
depend
rate
diseas
remiss
hematocrit
return
complet
normal
prednison
dosag
halv
mgkg
everi
day
kept
level
month
depend
fast
initi
remiss
achiev
longer
take
achiev
remiss
slower
therapi
withdrawn
prognosi
good
idiopath
case
mortal
day
b
c
relaps
uncommon
dog
idiopath
primari
iha
howev
iha
secondari
problem
longterm
prognosi
poorer
day
b
c
chronic
iha
chronic
iha
rel
uncommon
compar
peracut
subacut
form
anemia
develop
week
month
present
clinic
sign
lethargi
fatigu
pallor
unlik
subacut
iha
anemia
unrespons
almost
alway
coomb
antibodi
neg
system
sign
hepatosplenomegali
lymphadenopathi
icteru
appar
form
iha
probabl
associ
autoantibodi
react
surfac
antigen
present
red
cell
late
differenti
yet
releas
circul
explain
absenc
coomb
antibodi
posit
spherocytosi
indirect
coomb
test
sometim
posit
anim
red
cell
treat
bromelin
ficin
trypsin
incub
serum
treatment
may
expos
deepli
situat
antigen
present
circul
matur
red
cell
array
surfac
earlier
stage
differenti
expect
bone
marrow
show
either
hyperor
normalrespons
erythroid
seri
multipl
incompat
sometim
seen
crossmatch
even
though
anim
may
never
transfus
chronic
iha
differenti
congenit
red
blood
cell
enzym
defici
herit
spherocytosi
associ
erythrocyt
phosphofructokinas
american
cocker
spaniel
english
springer
spaniel
erythrocyt
pyruv
kinas
basenji
defici
giger
nobl
giger
et
al
chronic
iha
treat
initi
prednisolon
respons
day
cyclophosphamid
azathioprin
leflunomid
ad
regimen
blood
transfus
may
necessari
sustain
anim
therapi
take
effect
cold
agglutinin
diseas
cold
agglutinin
diseas
rare
type
iha
associ
autoantibodi
bind
red
cell
surfac
lower
core
bodi
temperatur
cold
agglutinin
usual
igm
class
often
idiopath
origin
clinic
manifest
diseas
usual
associ
cold
exposur
therefor
dog
cold
agglutinin
apt
seen
condit
colder
weather
colder
region
two
type
diseas
sign
may
occur
hemolyt
anemia
andor
gangren
distal
extrem
hemolyt
anemia
result
bind
cold
agglutinin
cooler
peripher
capillari
although
antibodi
detach
cell
return
core
bodi
complement
remain
bound
gangren
distal
extrem
result
agglutin
red
cell
smaller
vessel
pure
red
cell
aplasia
pure
red
cell
aplasia
human
occur
two
form
congenit
form
adult
acquir
form
congenit
form
human
known
syndrom
dianzani
et
al
syndrom
definit
famili
patient
sporad
remaind
adult
form
pure
red
cell
aplasia
associ
granular
lymphocyteprolif
disord
yamada
et
al
thymoma
masuda
et
al
drug
thompson
gale
parvoviru
infect
immun
diseas
tsai
et
al
develop
antibodi
either
recombinantli
deriv
natur
endogen
erythropoietin
prabhakar
muhlfeld
idiopath
pure
red
blood
cell
aplasia
dog
similar
human
diseas
congenit
idiopath
etiolog
observ
congenit
pure
red
cell
aplasia
occur
puppi
month
age
clinic
sign
includ
fatigu
extrem
pallor
young
anim
growth
may
retard
anemia
total
unrespons
wbc
platelet
count
normal
coomb
test
neg
spherocyt
absent
like
chronic
aiha
compat
donor
sometim
difficult
find
reason
higher
normal
incid
alloreact
antibodi
unknown
diagnost
tipoff
exist
marrow
aplasia
involv
one
celllin
aplasia
may
total
primit
rbc
precursor
cell
target
may
matur
arrest
later
stage
differenti
cell
target
specif
indic
immunemedi
diseas
rather
toxin
myeloprolif
disord
etc
treatment
ident
subacut
chronic
iha
except
time
must
allow
stem
cell
regener
anemia
began
respond
combin
therapi
usual
glucocorticoid
cyclophosphamid
bring
remiss
faster
glucocorticoid
alon
affect
puppi
often
need
transfus
wait
therapi
take
effect
prognosi
good
recurr
usual
seen
adult
onset
pure
red
cell
aplasia
ident
congenit
form
virtual
aspect
except
age
onset
onethird
dog
given
human
recombin
erythropoietin
also
develop
antierthropoietin
antibodi
sever
pure
red
cell
aplasia
within
one
month
treatment
immunemedi
thrombocytopenia
one
common
immunolog
disord
dog
breed
predilect
toward
poodl
associ
estru
intact
femal
dog
itp
dog
idiopath
case
like
iha
secondari
drug
feldman
sullivan
et
al
vaccin
elliott
ehrlichia
plati
e
cani
infect
harru
et
al
waner
et
al
neoplasia
grindem
et
al
immun
diseas
sle
aiha
idiopath
asymptomat
thrombocytopenia
describ
cavali
king
charl
spaniel
smedil
et
al
antiplatelet
antibodi
serum
affect
dog
found
react
membran
antigen
gp
iib
andor
iiia
similar
situat
human
lewi
meyer
platelet
antibodi
serum
elut
platelet
membran
found
react
homolog
platelet
case
lewi
meyer
frequent
present
clinic
sign
petechi
ecchymot
hemorrhag
skin
mucou
membran
hemorrhag
often
notic
clip
epistaxi
melena
hematuria
hyphema
even
neurolog
sign
may
seen
sever
case
substanti
blood
loss
anemia
dog
sever
itp
may
difficult
determin
whether
primari
problem
itp
secondari
hemorrhag
concurr
itp
imha
blood
loss
sourc
dic
critic
laboratori
find
thrombocytopenia
usual
platelet
ul
anemia
often
respons
accompani
case
either
iha
excess
blood
loss
platelet
blood
often
larg
bizarr
shape
megakaryocyt
bone
marrow
normal
number
increas
case
although
megakaryocyt
may
present
normal
increas
number
often
appear
immatur
fragment
fragil
megakaryocyt
sever
decreas
even
absent
case
find
suggest
pure
megakaryocyt
aplasia
clot
test
includ
pt
ptt
act
fdp
normal
antiplatelet
antibodi
determin
platelet
releas
test
present
less
case
fluoresc
antibodi
test
antiplatelet
antibodi
done
bone
marrow
smear
provid
megakaryocyt
present
sensit
kristensen
et
al
b
indirect
platelet
immunoflouresc
test
appear
higher
sensit
kristensen
et
al
b
adapt
latter
test
flow
cytometri
improv
sensit
use
sensit
bind
test
platelet
bound
antibodi
found
affect
dog
serum
antiplatelet
antibodi
lewi
meyer
lewi
et
al
rel
insensit
antiplatelet
antibodi
test
diagnosi
itp
usual
made
clinic
appear
respons
therapi
care
must
taken
rule
secondari
caus
itp
thrombocytopenia
two
main
find
influenc
mode
therapi
presenc
absenc
megakaryocyt
presenc
sever
associ
blood
loss
absenc
megakaryocyt
delay
anticip
therapeut
respons
week
greatli
effect
cost
prognosi
anim
sever
itp
blood
loss
anim
petechi
ecchymot
hemorrhag
without
seriou
blood
loss
glucocorticoid
treatment
alon
usual
suffic
azathioprin
cyclophosphamid
usual
ad
regimen
respons
day
thrombocytopenia
associ
sever
blood
loss
best
treat
prednisolon
vincristin
vincristin
frequent
decreas
normal
respons
time
day
day
fresh
whole
blood
collect
manner
preserv
platelet
requir
anim
manifest
sever
hemorrhag
case
itp
difficult
keep
remiss
safe
level
prednisolon
alon
even
combin
prednisolonecytotox
drug
therapi
case
consid
treat
prednisolon
leflunomid
danazol
prednisolon
drug
therapi
combin
splenectomi
statist
linkag
thrombocytopenia
eventu
develop
lymphoma
describ
dog
keller
affect
dog
time
like
develop
tumor
anim
gener
popul
mix
cytopenia
immun
natur
known
human
medicin
evan
syndrom
studi
patient
median
age
onset
year
rang
year
thrombocytopenia
anemia
neutropenia
pancytopen
matthew
et
al
intraven
immunoglobulin
glucocorticoid
first
line
therapi
variabl
effect
posit
respons
sustain
two
year
splenectomi
perform
patient
effect
median
one
month
treatment
includ
cyclosporin
vincristin
azathioprin
cyclophosphamid
danazol
cours
diseas
character
recurr
thrombocytopenia
hemolyt
anemia
neutropenia
two
year
onethird
patient
remiss
twothird
still
treatment
die
mix
cytopenia
close
resembl
human
evan
syndrom
occur
frequent
dog
predisposit
purebr
cocker
spaniel
like
human
diseas
affect
dog
usual
manifest
anemia
thrombocytopenia
detect
clinic
workup
vice
versa
mani
dog
evan
syndrom
also
leukopen
suggest
broadbas
attack
bone
marrow
variou
cytopenia
may
occur
simultan
manifest
variabl
attack
appear
one
degre
anoth
upon
subsequ
attack
care
must
taken
diagnos
evan
syndrom
dog
immuneor
nonimmunemedi
blood
loss
consumpt
thrombocytopenia
exampl
mani
dog
peracut
iha
associ
dic
consumpt
thrombocytopenia
true
dog
sever
babesiosi
haemobartonellosi
dog
evan
syndrom
less
like
respond
glucocorticoid
therapi
alon
difficult
get
remiss
combin
immunosuppress
drug
therapi
case
human
diseas
matthew
et
al
relaps
may
occur
vari
time
cessat
treatment
glucocorticoid
cyclosporin
therapi
indic
difficulttotreat
case
human
emilia
et
al
rackoff
manno
prove
use
dog
leflunomid
may
prove
signific
benefit
dog
refractori
diseas
autoimmun
neutropenia
rel
rare
disord
like
immun
cytopenia
occur
idiopath
secondari
form
secondari
diseas
usual
associ
drug
particular
anticonvuls
antibiot
jacob
et
al
must
differenti
premyeloprolif
diseas
herit
cyclic
neutropenia
autoimmun
neutropenia
usual
present
acut
fever
depress
profound
neutropenia
note
routin
cbc
bone
marrow
cytolog
either
normal
demonstr
hypercellular
granulocyt
seri
good
test
autoantibodi
neutrophil
usual
good
respons
longterm
prednisolon
combin
immunosuppress
drug
treatment
dog
may
go
develop
myeloid
neoplasia
alloimmun
hemolyt
anemia
transfus
reaction
transfus
reaction
common
alloimmun
disord
dog
dog
least
differ
dog
erythrocyt
antigen
dea
eight
intern
standard
hale
test
reagent
avail
six
eight
standard
canin
blood
type
dea
dea
strongli
antigen
dog
neg
blood
type
antibodi
lyric
antibodi
dea
lyric
caus
splenic
sequestr
subclin
destruct
transfus
red
cell
sever
day
period
antibodi
dea
effect
surviv
dea
posit
red
cell
reason
dea
posit
dog
consid
ideal
univers
donor
transfus
dea
posit
red
cell
dog
sensit
antigen
great
clinic
signific
transfus
dea
red
cell
dog
sensit
antigen
signific
term
transfus
efficaci
although
vast
major
sever
transfus
reaction
involv
alloantibodi
dea
least
one
dog
dea
neg
develop
highli
lyric
antibodi
undetermin
blood
type
follow
initi
transfus
second
transfus
dea
neg
donor
result
seriou
hemolyt
episod
callan
et
al
similar
situat
human
abo
cat
ab
blood
group
mani
dog
dea
neg
natur
occur
alloantibodi
blood
type
howev
given
infrequ
blood
group
nonlyr
natur
antidea
antibodi
natur
antibodi
great
clinic
signific
greatest
risk
dea
neg
dog
previous
transfus
blood
dea
posit
donor
dog
develop
sever
reaction
subsequ
transfus
dea
posit
blood
sensit
need
involv
previou
transfus
surpris
number
dog
iha
previou
transfus
histori
also
possess
alloantibodi
rang
red
cell
surfac
antigen
alloantibodi
clinic
signific
precis
red
cell
antigen
involv
anim
yet
determin
sever
sign
blood
incompat
usual
began
appear
within
min
transfus
earliest
sign
increas
puls
respir
shiver
fever
edema
face
angioneurot
edema
subsequ
sign
may
includ
hemoglobinuria
cardiac
arrythmia
pulmonari
edema
renal
shutdown
shock
dic
thrombosi
vessel
feet
tip
tail
ear
lead
gangren
death
recipi
donor
dog
must
crossmatch
prior
transfus
major
crossmatch
involv
test
serum
recipi
wash
rbc
donor
gross
agglutin
equal
volum
dilut
recipi
serum
salin
mix
equal
volum
suspens
wash
donor
rbc
salin
agglutin
appear
within
min
agglutinin
present
although
grossagglutin
test
prevent
donorrecipi
mismatch
author
observ
least
two
instanc
sever
transfus
reaction
occur
face
neg
agglutin
test
case
recipi
found
contain
nonagglutin
antibodi
donor
red
cell
indirect
coomb
test
indirect
coomb
test
involv
preincub
donor
rbc
recipi
serum
hour
wash
resuspend
salin
ad
coomb
reagent
agglutin
occur
addit
coomb
reagent
evid
presenc
nonagglutin
antibodi
recipi
serum
minor
crossmatch
involv
test
donor
serum
recipi
rbc
agglutin
indic
serum
donor
may
react
donor
rbc
follow
transfus
plasma
compon
given
along
rbc
reaction
minor
clinic
signific
henc
term
minor
crossmatch
incompat
nonetheless
minor
mismatch
transfus
done
situat
better
match
donor
avail
blood
transfus
dog
alway
undertaken
care
harrel
kristensen
order
avoid
transfus
reaction
donor
recipi
crossmatch
prior
transfus
done
even
donor
dea
neg
blood
transfus
slowli
first
min
whenev
possibl
advers
reaction
note
first
minut
transfus
abort
worst
thing
given
blood
prior
onset
advers
sign
pretreat
antihistamin
corticosteroid
prevent
reaction
occur
may
make
somewhat
milder
sever
transfus
reaction
occur
treat
massiv
dosag
steroid
control
shock
support
renal
function
prepar
give
oxygen
immun
complex
vascul
observ
follow
acut
transfus
reaction
lead
major
tissu
infarct
h
initi
sign
pass
neonat
isoerythrolysi
neonat
isoerytholysi
describ
puppi
associ
mainli
dea
hale
small
proport
dea
neg
bitch
sensit
dea
carri
dea
posit
puppi
probabl
transplacent
leakag
fetal
red
cell
bitch
make
alloantibodi
dea
pass
puppi
colostrum
clinic
sign
appear
within
first
day
two
nurs
includ
anemia
lethargi
jaundic
tachypnea
tachycardia
hepatosplenomegali
occasion
hemoglobinuria
mildli
affect
puppi
treat
symptomat
rest
good
nurs
care
sever
affect
puppi
may
requir
extens
blood
transfus
doubt
donor
use
wash
plasmafre
rbc
bitch
obviou
choic
neglig
chanc
destroy
puppi
myasthenia
gravi
occur
acquir
autoimmun
congenit
famili
genet
form
man
dog
congenit
form
immun
basi
acquir
form
associ
product
antibodi
acetylcholin
receptor
antibodi
lead
diminut
structur
postsynapt
sarcolemma
acquir
form
far
common
congenit
form
dog
incid
acquir
myasthenia
gravi
dog
even
greater
human
similar
human
diseas
myasthenia
gravi
dog
observ
sequela
thymoma
howev
relationship
nearli
common
dog
peopl
lainess
et
al
rusbridg
et
al
studi
canin
thymoma
anim
megaesophagu
myasthenia
gravi
confirm
seven
atwat
et
al
paradox
one
dog
develop
clinic
sign
myasthenia
gravi
remov
thymoma
none
dog
evid
distant
metastasi
histolog
predomin
tumor
type
differentiatedepitheli
lymphocyterich
shelton
et
al
studi
dog
resid
within
unit
state
acquir
myasthenia
gravi
purebr
dog
greater
risk
mixedbre
dog
highest
risk
acquir
myasthenia
gravi
akita
terrier
group
scottish
terrier
german
shorthair
pointer
chihuahua
rottweil
doberman
pinscher
dalmatian
jack
russel
terrier
low
rel
risk
sexual
intact
male
dog
less
one
year
old
protect
risk
sever
clinic
form
acquir
myasthenia
gravi
describ
dewey
et
al
webb
et
al
onethird
affect
dog
histor
clinic
evid
appendicular
muscl
weak
design
focal
myasthen
dog
focal
myasthenia
usual
exhibit
weak
facial
pharyng
laryng
muscl
twothird
myasthen
dog
present
system
diseas
usual
combin
appendicular
weak
megaesophagu
system
form
myasthenia
dog
subdivid
chronic
gener
acut
fulmin
form
onefourth
dog
fulmin
onset
threefourth
chronic
dog
system
myasthenia
regardless
form
manifest
sign
megaesophagu
smaller
proport
demonstr
facial
laryng
pharyng
weak
histor
evid
exerciseassoci
appendicular
weak
observ
onehalf
dog
chronic
gener
myasthenia
gravi
dog
acut
fulmin
myasthenia
gravi
usual
present
sudden
weak
onehalf
dog
either
chronic
fulmin
gener
myasthenia
demonstr
primarili
pelvic
limb
weak
third
degre
atrioventricular
block
diagnos
four
dog
acquir
myasthenia
gravi
megaesophagu
hackett
et
al
two
dog
also
mediastin
thymoma
three
dog
seri
thymoma
also
develop
thirddegre
atrioventricular
heart
block
one
gener
myositi
involv
cardiac
muscl
atwat
et
al
therefor
heart
problem
may
complic
myasthenia
gravi
dog
diagnosi
myasthenia
gravi
base
signal
ie
breed
age
histori
clinic
find
result
iv
edrophonium
chlorid
administr
electromyograph
find
decrement
reduct
amplitud
repetit
nerv
stimul
presenc
absenc
muscl
membran
stain
immunocytochem
method
serum
acetylcholin
receptor
antibodi
concentr
holland
et
al
treatment
outcom
acetylcholin
receptor
antibodi
titer
nmoll
consid
diagnost
acquir
myasthenia
gravi
one
half
myasthen
dog
die
euthanat
shortli
admiss
hospit
due
aspir
pneumonia
dog
acut
fulmin
myasthenia
gravi
markedli
higher
oneyear
mortal
rate
comparison
two
group
princip
treatment
anticholinerg
pyridostigmin
bromid
usual
improv
overal
muscl
strength
addit
use
immunosuppress
therapi
signific
posit
effect
patient
surviv
regardless
type
myasthenia
gravi
surgic
remov
thymoma
dog
tumor
mix
result
two
german
shepherd
dog
diseas
resolv
satisfactori
control
clinic
sign
anticholinesteras
treatment
rusbridg
et
al
surgic
remov
thymic
mass
older
cocker
spaniel
result
rapid
resolut
clinic
sign
decreas
serum
antibodi
concentr
sign
recur
six
month
postop
regrowth
thymoma
lainess
et
al
two
dog
thymoma
megaesophagu
third
degre
heart
block
die
aspir
pneumonia
within
three
month
surgic
resect
tumor
hackett
et
al
equal
poor
result
obtain
larger
studi
six
nine
dog
thymoma
megaesophagu
underw
surgeri
die
euthanat
within
one
week
diagnosi
atwat
et
al
dog
appear
uniqu
suscept
autoimmun
disord
involv
masticatori
muscl
lewi
purebr
predispos
condit
cocker
spaniel
may
repres
specif
diseas
probabl
relat
uniqu
structur
muscl
dog
masticatori
muscl
dog
uniqu
myofib
protein
myosin
enzym
myosin
light
heavi
chain
compar
limb
muscl
shelton
et
al
shelton
et
al
b
autoantibodi
uniqu
type
fiber
protein
found
bound
muscl
free
serum
antibodi
target
includ
kda
protein
myosin
heavi
chain
light
masticatori
myosin
masticatori
myopathi
may
manifest
acut
swell
tempomandibular
muscl
sever
pain
open
mouth
mani
dog
howev
acut
stage
goe
unnot
muscl
diseas
chronic
lowgrad
muscl
slowli
atrophi
replac
fibrou
tissu
obviou
pain
first
clinic
abnorm
often
manifest
difficulti
eat
drink
associ
inabl
open
mouth
result
muscl
tendon
contractur
eosinophilia
may
may
present
diagnosi
usual
base
characterist
clinic
sign
muscl
biopsi
antibodi
measur
serum
normal
masticatori
muscl
protein
affect
dog
treat
initi
high
dose
prednisolon
jaw
slowli
begin
open
sever
week
treatment
although
usual
never
back
normal
treatment
discontinu
therefor
anim
open
mouth
enough
eat
drink
comfort
bullou
dermatitid
character
format
autoantibodi
variou
intracellular
cement
protein
mucocutan
junction
andor
skin
bind
antibodi
intracellular
cement
lead
breakdown
bond
variou
cell
layer
lead
cleft
fill
fluid
form
blister
bulla
blister
rapidli
ruptur
leav
underli
ulcer
vari
depth
accord
layer
epidermi
affect
layer
epidermi
affect
turn
depend
particular
intracellular
cement
substanc
target
attack
lesion
tend
concentr
mucocutan
junction
mouth
eye
anu
vulva
prepuc
skin
certain
area
bodi
depend
particular
diseas
pemphigu
foliac
surprisingli
common
dog
associ
format
autoantibodi
epiderm
protein
kda
iwasaki
et
al
iwasaki
et
al
kda
protein
size
human
desmoglein
predomin
antigen
target
pemphigu
foliac
peopl
diseas
occur
predominantli
purebr
larg
number
breed
repres
kuhl
et
al
howev
akita
english
springer
spaniel
chow
chow
chines
shar
pei
colli
time
like
develop
pemphigu
foliac
breed
pemphigu
foliac
dog
usual
occur
age
two
seven
year
gradual
case
rapidli
progress
case
superfici
bullou
dermatitid
lesion
gener
patchi
facial
case
pedal
orient
lesion
dog
appear
first
bridg
nose
lesion
character
crust
scale
alopecia
insid
mouth
usual
unaffect
diseas
akita
less
often
breed
may
associ
uveiti
case
may
mistaken
voightkoronadaharada
vkh
syndrom
occur
commonli
peopl
japanes
extract
vkh
due
cellmedi
autoimmun
attack
melanocyt
human
often
manifest
uveiti
mening
depig
skin
lesion
vkhlike
syndrom
occur
dog
mainli
chow
chow
biopsi
affect
skin
dog
pemphigu
foliac
show
vesicopustul
directli
beneath
stratum
corneum
subcorn
pustul
microabscess
may
also
observ
within
extern
root
sheath
within
hair
follicl
pustul
fill
acantholyt
keratinocyt
neutrophil
eosinophil
indirect
fluoresc
immunoperoxidas
antibodi
stain
show
subcorn
deposit
immunoglobulin
area
intracellular
cement
shinya
et
al
sera
affect
dog
antibodi
react
bovin
esophagu
bovin
esophagu
substrat
choic
compar
bovin
nose
tongu
monkey
esophagu
canin
nose
iwasaki
et
al
anim
respond
high
dose
steroid
treatment
follow
mainten
treatment
drugfre
remiss
rare
anim
fail
respond
well
glucocorticoid
alon
requir
toxic
level
keep
diseas
control
treat
glucocorticoid
azathioprin
glucocorticoid
cyclophosphamid
glucocorticoid
gold
salt
drug
toxic
becom
problem
time
difficulti
achiev
full
remiss
sustain
remiss
treatment
discontinu
leflunomid
glucocorticoid
use
combin
may
provid
better
longterm
control
less
sideeffect
pemphigu
vulgari
much
less
common
condit
pemphigu
foliac
predomin
purebr
unlik
pemphigu
foliac
tend
spare
mucocutan
junction
pemphigu
vulgari
predilect
mucocutan
junction
mouth
eye
nostril
anu
prepuc
rectum
nippl
mucosa
insid
mouth
cheek
palat
tongu
involv
nail
bed
also
seen
lesion
frequent
secondarili
infect
bacteria
pain
prurit
affect
anim
often
system
ill
demonstr
malais
weight
loss
intact
vesicl
sometim
seen
upon
frequent
care
examin
mucou
membran
blister
due
subrabasil
cleft
form
around
acantholyt
keratinocyt
sign
secondari
bacteri
infect
inflamm
common
pemphigu
foliac
may
need
treat
secondari
bacteri
infect
initi
stage
therapi
howev
remiss
difficult
achiev
longterm
prognosi
even
wors
bullou
pemphigoid
uncommon
among
breed
dog
shetland
sheepdog
colli
perhap
doberman
pinscher
may
overrepres
dog
usual
affect
young
adult
lesion
appear
deep
ulcer
skin
mucocutan
junction
often
outward
appear
similar
fullthick
burn
lesion
concentr
mucocutan
junction
oral
caviti
anu
vulva
prepuc
skin
axilla
groin
bulla
may
seen
upon
care
examin
bulla
involv
separ
entir
epidermi
dermi
along
basal
lamina
indirect
fluoresc
antibodi
stain
demonstr
bind
igg
basal
lamina
autoantibodi
one
dog
found
react
kd
glycoprotein
canin
skin
analog
kd
bullou
pemphigoid
bp
antigen
human
iwasaki
et
al
condit
carri
poor
prognosi
due
difficulti
achiev
maintain
full
remiss
treatment
choic
glucocorticoid
use
combin
azathioprin
combin
glucocorticoidleflunomid
therapi
need
evalu
condit
microbi
infect
gener
immun
complex
case
acut
diseas
influenza
complex
exist
period
time
organ
activ
replic
time
howev
may
contribut
overal
clinic
syndrom
eg
transient
muscl
joint
pain
fever
etc
persist
immunecomplex
relat
sign
may
occur
howev
infect
becom
chronic
four
type
interact
drug
tissu
lead
antibodi
drug
bind
directli
tissu
protein
drugcarri
complex
form
antibodi
direct
drug
hapten
moieti
drug
biotransform
haptenogen
compound
bind
tissu
protein
elicit
antibodi
biotransform
drug
metabolit
interact
tissu
form
new
antigen
site
drug
metabolit
react
tissu
caus
conform
chang
tissu
protein
render
antigen
serum
sick
classic
diseas
result
use
heterolog
antiserum
immun
serum
use
treatment
prevent
certain
infect
toxic
initi
inocul
foreign
protein
antibodi
appear
three
seven
day
immun
complex
form
clinic
sign
fever
lymphadenopathi
rash
joint
muscl
pain
appear
sign
persist
foreign
protein
bound
complex
remov
system
certain
immun
complex
diseas
involv
antibodi
selfantigen
immun
complex
sle
consist
antinuclear
antibodi
correspond
nuclear
antigen
rheumatoid
arthriti
ra
man
possibl
ra
dog
autoantibodi
produc
denatur
immun
complex
igg
autoantibodi
call
rheumatoid
factor
rheumatoid
factor
also
appear
blood
anim
chronic
infect
rheumatoid
factor
one
way
bodi
clear
smallers
immun
complex
rheumatoid
factor
pathogen
product
excess
case
may
contribut
immun
complex
diseas
rheumatoid
arthriti
peopl
immun
complex
larg
size
creat
zone
antibodi
excess
clear
directli
system
small
complex
creat
zone
antigen
excess
small
move
freeli
intraand
extracellular
fluid
space
immun
complex
gener
condit
slight
antigen
excess
howev
intermedi
size
like
deposit
endothelium
immun
complex
proper
configur
pass
endotheli
gap
becom
embed
within
basement
membran
immun
complex
may
also
form
situ
area
basement
membran
rather
carri
preform
fashion
site
occur
situat
protein
basement
membran
immunogen
situat
free
antigen
trap
basement
membran
antibodi
antigen
gener
later
time
likelihood
immun
complex
deposit
given
organ
depend
sever
factor
physic
anatom
makeup
endotheli
bed
rel
blood
flow
organ
condit
increas
vascular
permeabl
ie
histamin
releas
specif
chemic
makeup
charg
complex
genet
factor
immun
complex
equilibrium
free
antigen
antibodi
tissu
rate
complex
deposit
vari
therefor
amount
antigen
antibodi
form
given
period
time
immun
complex
format
normal
reaction
acut
infecti
antigenreleas
disord
complex
deposit
acut
basement
membran
rapidli
dissolv
period
antibodi
excess
convalesc
reach
occur
perman
damag
basement
membran
deposit
immun
complex
per
se
lead
diseas
problem
aris
host
respond
complex
local
inflammatori
reaction
elicit
immun
complex
initi
thought
caus
local
inflamm
bind
complement
attract
neutrophil
area
inflammatori
mediat
releas
neutrophil
ultim
respons
lesion
immun
complex
lesion
howev
also
occur
absenc
neutrophil
complement
role
macrophag
macrophag
kinin
immunecomplex
induc
inflamm
current
import
area
studi
macrophag
one
consist
inflammatori
cell
found
immun
complex
lesion
discuss
sle
dog
prefac
descript
diseas
peopl
lupu
wolflik
refer
patchi
depigment
erythema
skin
face
human
sle
howev
skin
lesion
one
part
syndrom
fact
virtual
everi
organ
system
bodi
affect
peopl
sle
sle
common
disord
seen
human
affect
femal
male
black
white
patient
year
age
first
sign
seen
particularli
high
incid
year
age
group
famili
cluster
peopl
offspr
affect
individu
twofold
higher
incid
rel
peopl
clinic
sle
often
serolog
evid
diseas
clinic
sign
human
sle
like
leukocyt
type
nonaffect
individu
found
strong
posit
relationship
sle
german
shepherd
dog
neg
relat
teichner
et
al
diseas
man
run
sever
cours
fulmin
diseas
rapid
progress
sign
cyclic
diseas
first
attack
sever
frequent
period
year
attack
becom
milder
apart
chronic
lowgrad
diseas
occasion
interrupt
period
increas
diseas
activ
serolog
posit
individu
sign
ill
number
organ
system
involv
sle
tendenc
howev
diseas
local
one
two
organ
lifethreaten
complic
sle
man
kidney
failur
follow
frequenc
neurolog
complic
surviv
rate
peopl
sle
exce
sle
recogn
almost
speci
anim
veterinari
import
best
describ
howev
dog
canin
sle
preval
perhap
human
counterpart
occur
mainli
purebr
especi
sport
breed
spaniel
pointer
retriev
german
shepherd
dog
doberman
pinscher
also
common
mani
nonsport
breed
spitz
poodl
usual
age
onset
dog
year
age
case
occur
year
rang
similar
proportion
age
incid
peopl
sle
often
diagnos
basi
presenc
certain
typic
symptom
absenc
exclusionari
diseas
attempt
made
util
criteria
canin
sle
howev
human
criterium
strictli
adher
dog
sle
would
qualifi
dog
tend
one
two
system
sign
often
polyarthr
skin
hematolog
cn
renal
manifest
less
import
pedersen
et
al
krum
et
al
monier
et
al
slappendel
et
al
etiolog
sle
man
anim
determin
although
gender
genet
play
role
estrogen
enhanc
diseas
testosteron
protect
close
rel
sle
patient
time
like
develop
sle
man
almost
differ
drug
particular
hydralazin
procainamid
also
induc
lupuslik
syndrom
drug
induc
diseas
differ
howev
natur
occur
sle
follow
way
sex
ratio
equal
nephriti
cn
sign
seen
serum
complement
level
usual
normal
antibodi
nativ
dna
absent
clinic
laboratori
abnorm
return
normal
drug
discontinu
sle
seen
less
age
cat
chronic
treat
prophylthiouracil
hyperthyroid
drug
induc
sle
describ
dog
sle
man
anim
mani
featur
common
hallmark
antinuclear
antibodi
ana
ana
seem
produc
respons
slow
insidi
releas
nucleic
acid
presenc
hyperrespons
immun
system
form
ana
react
slowli
releas
nucleic
acid
form
immun
complex
antinuclear
antibodi
direct
singl
strand
denatur
dna
ssdna
salin
solubl
extract
nondna
nuclear
antigen
sm
smith
nuclear
antigen
histon
ribonucleoprotein
goudswaard
et
al
monesti
et
al
thorentol
ryden
white
et
al
antibodi
nuclear
glycoprotein
associ
dna
also
detect
dog
sle
soulard
et
al
antibodi
doubl
strand
dna
hallmark
human
sle
may
import
dog
jone
unlik
situat
seen
type
ii
immun
diseas
antinuclear
antibodi
pathogen
mother
sle
pass
high
titer
ana
babi
evid
diseas
infant
furthermor
sle
peopl
anim
sometim
occur
absenc
detect
ana
seroneg
lupu
definit
individu
sle
ana
diagnost
criteria
diseas
syndrom
ana
neg
individu
otherwis
indistinguish
sle
call
prototyp
immun
complex
diseas
circul
immun
complex
pass
endotheli
cell
junction
trap
underli
basement
membran
complement
bound
complex
turn
lead
influx
polymorphonuclear
cell
local
inflamm
reaction
local
around
blood
vessel
henc
vascul
one
hallmark
sle
vascular
reaction
occur
glomeruli
glomerulonephr
result
vascul
synovi
blood
vessel
result
synov
mening
vesselsmening
retin
vesselsuv
seros
vesselsperiton
pleuriti
spinal
cord
vesselstransvers
myelopathi
cardiac
vesselsmyocard
pericardi
blood
vesselspancreat
gi
tractcol
ulcer
etc
immun
complex
skin
usual
found
around
small
dermal
vessel
basal
lamina
deposit
immun
complex
skin
alway
caus
lesion
potenti
exposur
solar
radiat
lesion
extrem
face
hand
ear
bridg
nose
etc
therefor
strike
peopl
anim
sle
suffer
sever
immunolog
abnorm
besid
immun
complex
diseas
sle
associ
state
immunolog
hyper
respons
mainli
bcell
system
defici
tsuppressor
lymphocyt
increas
antibodi
level
mani
common
antigen
especi
viral
origin
individu
sle
also
greater
normal
propens
make
autoantibodi
especi
rbc
platelet
leukocyt
antigen
antibodi
coagul
protein
circul
anticoagul
develop
human
sle
report
dog
stone
et
al
anticoagul
phospholipid
intrins
clot
factor
factor
viii
antibodi
caus
thrombot
hemorrhag
complic
peopl
dog
human
sle
also
frequent
develop
fals
posit
serolog
test
syphili
due
develop
crossreact
antibodi
phospholipid
present
mani
organ
syphili
spirochet
dog
sle
produc
antibodi
heat
shock
protein
bell
et
al
human
sle
develop
rheumatoid
factor
similar
proport
dog
sle
chabann
et
al
rheumatoid
factor
antibodi
igm
react
immun
complex
denatur
igg
lymphocytotox
antibodi
also
detect
serum
human
canin
patient
common
featur
sle
dog
cyclic
antibiot
unrespons
fever
accompani
one
organ
specif
sign
polyarthr
occur
peopl
anim
sle
noneros
inflammatori
arthriti
proxim
joint
less
sever
involv
distal
joint
anim
show
gener
stiff
difficulti
get
lay
shift
limb
lame
polymyos
polyneur
may
also
occur
dog
seldom
seen
usual
accompani
polyarthr
krum
pleuriti
frequent
seen
radiograph
dog
florid
sle
usual
clinic
appar
skin
lesion
uncommon
accompani
featur
dog
compar
human
macular
erythemat
crusti
sometim
ulcer
lesion
usual
face
bridg
nose
eyebrow
ear
margin
lip
dermat
seen
often
predomin
featur
ulcer
infarct
lesion
palat
tongu
digit
accompani
primari
featur
sle
dog
neurolog
sign
seen
human
uncommon
dog
transvers
myelopathi
uncommon
sequela
sle
dog
peopl
leukopenia
common
sign
sle
man
uncommon
dog
glomerulonephr
histolog
immunohistolog
diagnosi
common
dog
sle
much
less
like
progress
renal
failur
peopl
dog
present
iha
itp
serolog
evid
sle
convers
small
portion
dog
immun
complex
ie
vascul
manifest
sle
concurr
iha
itp
diagnosi
sle
base
signal
breed
predisposit
age
diseas
sign
compat
system
vascul
andor
autoimmun
cytopenia
ana
posit
fluoresc
ana
fana
test
standard
screen
test
type
ana
fana
indirect
immunofluoresc
assay
serial
dilut
patient
serum
react
aceton
fix
cell
cultur
monolay
usual
human
mous
hepatoma
cell
rat
liver
section
mcvey
shuman
thorentol
ryden
fana
titer
anim
usual
low
compar
man
normal
anim
ana
posit
ana
diagnost
occur
appropri
clinic
manifest
sle
origin
lupu
erythematosu
le
cell
procedur
mani
fals
posit
neg
dog
seldom
use
sle
dog
treat
similar
manner
sle
peopl
initi
attack
diseas
usual
worst
must
treat
vigor
initi
treatment
often
consist
glucocorticoid
alon
although
combin
immunosuppress
therapi
ultim
requir
mani
affect
dog
diseas
brought
remiss
kept
way
minimum
drug
therapi
onehalf
anim
may
withdrawn
therapi
six
month
year
remaind
must
treat
indefinit
glomerulonephr
present
difficult
part
syndrom
treat
diseas
manifest
apt
clinic
silent
substanti
organ
damag
occur
therefor
renal
function
period
monitor
even
sign
sle
appear
control
ana
disappear
anim
full
remiss
reappear
upon
relaps
therefor
good
monitor
diseas
control
discoid
lupu
common
diseas
nasal
planum
dog
especi
region
high
solar
radiat
white
diseas
occur
commonli
purebr
long
nose
confirm
especi
colli
shetland
sheepdog
diseas
consid
focal
form
sle
deposit
immun
complex
basement
membran
nuclear
antigen
extract
lesion
least
one
dog
discoid
lupu
suggest
help
make
immun
complex
white
et
al
diseas
basement
membran
render
skin
suscept
effect
solar
radiat
focus
intens
nasal
planum
nose
result
low
grade
inflamm
nasal
planum
depigment
constant
lick
lesion
lead
addit
damag
nose
increas
number
epiderm
langerhan
cell
express
mhc
class
ii
seen
dog
discoid
lupu
pemphigu
foliac
day
b
c
antinuclear
antibodi
usual
found
circul
observ
occas
iwasaki
et
al
treatment
immunosuppress
drug
usual
glucocorticoid
sun
screen
avoid
sunlight
combin
tetracyclin
niacinamid
also
shown
promis
dog
discoid
lupu
white
et
al
deposit
complex
complement
blood
vessel
wall
caus
vari
degre
inflamm
hemorrhag
thrombosi
necrosi
associ
tissu
form
vascul
signific
dermal
compon
although
lesion
may
seen
simultan
varieti
addit
organ
sever
predispos
caus
includ
drug
chronic
infecti
diseas
autoimmun
diseas
sle
drug
induc
vasculitid
well
document
dog
noli
et
al
sulfa
drug
includ
trimethoprimsulfa
erythromycin
lincomycin
frequent
offend
dog
gold
salt
barbitur
phenylbutazon
indomethacin
phenytoin
ibuprofen
thiazid
quinin
penicillin
synthet
penicillin
aspirin
procainamid
phenothiazin
antithyroid
drug
prophylthiouracil
carbimazol
number
drug
commonli
associ
syndrom
peopl
potenti
see
drug
induc
vascul
dog
undoubtedli
increas
sophist
veterinari
medicin
increas
anim
treat
wider
rang
drug
longer
period
time
drug
reaction
consist
two
compon
type
dermal
erupt
without
system
sign
fever
arthralgia
drug
erupt
peopl
dermat
medicamentosa
classifi
follow
categori
toxic
erythema
rash
erythema
multiform
bullou
lesion
frequent
bloodi
erythema
nodosum
patchi
erythemat
lesion
allerg
vascul
lesion
rang
urticaria
necrot
ulcer
purpura
petechi
ecchymot
hemorrhag
skin
eczema
exfoli
dermat
entir
skin
surfac
red
scali
photosensit
skin
lesion
potenti
sunlight
lesion
frequent
expos
area
skin
drugrel
sle
lichenoid
erupt
flattop
papul
often
scale
dermal
chang
fix
erupt
erythemat
plaqu
occur
spot
time
drug
reinstitut
toxic
epiderm
necrolysi
uncommon
condit
sever
consequ
case
larg
area
skin
becam
devascular
urticaria
pruritu
itchi
skin
without
obviou
lesion
hair
loss
pigmentari
chang
skin
virtual
form
seen
dog
vari
degre
numer
disord
erythema
multiform
allerg
vascul
drugrel
sle
toxic
epiderm
necrolysi
like
caus
immun
complex
mediat
vascular
damag
characterist
clinic
featur
condit
abrupt
appear
skin
lesion
character
focal
hemorrhag
inflamm
tissu
death
tissu
slough
toxic
epiderm
necrolysi
sever
diseas
larg
segment
skin
becom
devit
gangren
histopatholog
lesion
extrem
vari
vascul
compon
sometim
difficult
appreci
diagnosi
made
basi
appear
lesion
tempor
relationship
drug
therapi
diagnosi
confirm
respons
drug
withdraw
vascul
one
form
anoth
common
featur
mani
chronic
infecti
diseas
glomerulonephr
uveiti
polyarthr
dermatopathi
describ
wide
rang
infect
monocyt
granulocyt
ehrlichiosi
rocki
mountain
spot
fever
lyme
borreliosi
dirofilariasi
pyometra
infecti
canin
hepat
deep
mycot
infect
viscer
leishmaniasi
vascul
may
accompani
immun
diseas
dog
sle
rheumatoid
arthriti
hypothyroid
name
impli
anim
idiopath
vascul
identifi
predispos
caus
human
diseas
type
includ
leukocytoclast
angiiti
polyarter
nodosa
giant
cell
arter
allerg
granulomatosi
wegen
granulomatosi
condit
similar
diseas
seen
dog
whether
diseas
anim
exact
analogu
howev
remain
proven
idiopath
vascul
dog
usual
manifest
ulcer
lesion
palat
tongu
lower
limb
digit
system
vascul
widespread
petechia
ecchymos
subcutan
hemorrhag
observ
italian
greyhound
condit
resembl
purpura
hemorrhagica
man
idiopath
cutan
vascul
necot
glomerul
describ
race
greyhound
carpent
et
al
cowan
et
al
system
recort
vascul
report
nine
young
beagl
scottmoncrieff
et
al
acut
chronic
edema
especi
one
hind
limb
may
also
unusu
manifest
idiopath
vascul
dog
diagnosi
idiopath
vascul
made
confirm
presenc
vascul
deep
biopsi
rule
possibl
secondari
caus
treatment
similar
immun
diseas
start
glucocorticoid
alon
ad
immunosuppress
agent
necessari
noneros
noninfecti
arthriti
occur
dog
though
etiolog
divers
probabl
mediat
similar
immunopatholog
mechan
pedersen
et
al
pederson
pool
present
clinic
sign
type
arthriti
similar
whether
idiopath
associ
secondari
infecti
diseas
sle
neoplasia
inflammatori
bowel
diseas
drug
hypersensit
joint
diseas
tend
cyclic
natur
predisposit
smaller
distal
joint
carpu
tarsu
particular
occur
monarticular
rare
pauciarticular
uncommon
polyarticular
common
form
radiograph
chang
even
mani
month
joint
diseas
tend
minim
nonexist
limit
soft
tissu
swell
biopsi
synovi
membran
show
nonvil
hyperplasia
spars
mononuclear
cell
infiltr
neutrophil
infiltr
fibrin
exud
margin
eros
pannu
format
promin
featur
diseas
regardless
overli
underli
diseas
process
lead
arthriti
joint
diseas
believ
due
deposit
immun
complex
synovi
membran
result
type
iii
immun
ie
vascul
reaction
idiopath
nondeform
arthriti
origin
natur
antigen
complex
unknown
antigen
sle
nuclear
origin
antigen
enteropath
arthriti
probabl
origin
inflam
bowel
antigen
arthriti
secondari
chronic
infecti
diseas
neoplasia
origin
offend
microorgan
tumor
cell
idiopath
nondeform
arthriti
idiopath
nondeform
arthriti
far
common
disord
dog
manifest
immunemedi
arthriti
pedersen
et
al
pederson
pool
term
idiopath
evid
underli
diseas
disord
occur
predominantli
purebr
although
feel
medium
larger
sportingtyp
breed
affect
condit
also
observ
mani
small
breed
possibl
associ
immunemedi
thyroid
hypothyroid
may
exist
numer
breed
suffer
hypothyroid
among
breed
commonli
affect
idiopath
nondeform
arthriti
idiopath
nondeform
polyarthr
also
recogn
cat
much
less
frequent
dog
diseas
usual
manifest
anim
year
age
unusu
puppi
adolesc
older
dog
initi
present
histori
one
cyclic
fever
malais
anorexia
lame
gener
stiff
note
fever
pronounc
dog
polyarticular
diseas
least
pronounc
anim
monarticular
involv
sever
affect
dog
period
remiss
usual
incomplet
case
diseas
debilit
gener
muscl
atrophi
disproportion
atrophi
tempor
masset
muscl
frequent
seen
atrophi
due
part
disus
mani
case
diseas
process
also
involv
muscl
nerv
sever
stage
diseas
swell
heat
distal
joint
sometim
detect
gener
lymphadenopathi
may
note
vari
degre
period
diseas
activ
leukocytosi
neutrophilia
hyperfibrinogenemia
often
observ
polyarticular
involv
common
present
dog
show
gener
stiff
reluct
move
spine
tail
limb
toy
breed
often
sever
gener
arthriti
becom
virtual
immobil
make
difficult
tell
whether
joint
sourc
problem
whether
immobl
due
sole
depress
radiograph
abnorm
usual
present
except
increas
amount
periarticular
soft
tissu
due
inflamm
fibrosi
diseas
present
mani
month
without
treatment
howev
mild
degen
chang
occur
joint
persist
hyperemia
synovium
lead
sever
periarticular
periost
bone
prolifer
rare
individu
radiograph
abnorm
lead
mistaken
diagnosi
degen
joint
diseas
djd
obvious
misdiagnosi
greatli
influenc
type
therapi
select
import
therefor
alway
take
sampl
synovi
fluid
dog
djd
chang
atyp
diseas
diagnosi
made
consider
clinic
histori
antibioticunrespons
cyclic
fever
malais
anorexia
upon
superimpos
stiff
lame
cyclic
natur
diseas
complic
diagnosi
affect
dog
may
appear
respond
favor
antibiot
therapi
fact
improv
due
coincident
cyclic
variat
inflammatori
process
synovi
fluid
analysi
imper
even
sign
joint
pain
swell
redden
pedersen
synovi
fluid
affect
individu
contain
white
cell
per
ml
predomin
cell
fluid
neutrophil
cell
appear
nontox
normal
granul
fluid
steril
bacteria
virus
mycoplasma
chlamydia
serolog
abnorm
le
cell
phenomenon
antinuclear
antibodi
rheumatoid
factor
absent
blood
cultur
neg
bacteria
sign
primari
infecti
process
area
bodi
treatment
involv
use
glucocorticoid
alon
combin
potent
immunosuppress
drug
see
section
complet
remiss
sign
usual
achiev
dog
recurr
ill
drug
therapi
discontinu
nondeform
arthriti
associ
chronic
infecti
diseas
nondeform
arthriti
associ
chronic
infecti
diseas
describ
dog
pedersen
et
al
bennett
van
der
wel
meyer
type
arthriti
associ
subacut
bacteri
endocard
pyometra
discospondyl
chronic
actinomyc
infect
chest
abdomen
paravertebr
musculatur
chronic
salmonellosi
heartworm
diseas
urinari
tract
infect
sever
periodont
sinc
infect
often
difficult
pinpoint
arthriti
may
main
sole
present
complaint
import
therefor
make
thorough
search
secondari
infect
everi
time
noneros
type
arthriti
found
especi
import
immunosuppress
drug
contraind
anim
underli
infect
joint
involv
type
disord
usual
monarticular
pauciarticular
predisposit
carpal
tarsal
joint
sinc
organ
involv
primari
diseas
process
identifi
synovi
membran
like
joint
diseas
also
immun
complex
origin
similar
relationship
steril
arthriti
chronic
infect
part
bodi
recogn
much
earlier
man
coggeshal
et
al
nondeform
arthriti
associ
immun
disord
system
lupu
erythematosu
nondeform
polyarthr
common
present
clinic
featur
canin
sle
like
virtual
immunemedi
arthritid
care
must
taken
exclud
underli
caus
diseas
eg
infect
drug
neoplasia
noneros
polyarthr
observ
subacut
bacteri
endocard
sbe
man
dog
inde
entir
syndrom
sbe
mimic
sle
two
dog
describ
bennett
best
document
point
chronic
bacteri
endocard
lead
continu
lowgrad
damag
parenchym
organ
high
level
circul
immun
complex
heighten
respons
host
immun
system
man
anim
may
result
product
numer
autoantibodi
includ
antinuclear
antibodi
rheumatoid
factor
antinuclear
antibodi
result
chronic
nucleoprotein
releas
heighten
immunolog
respons
rheumatoid
factor
made
respons
persist
immunecomplex
product
phenomenon
import
anim
mistakenli
diagnos
sle
rheumatoid
arthriti
treat
immunosuppress
drug
potenti
seriou
consequ
immunemedi
polyarthr
mening
paucior
polyarticular
arthriti
accompani
featur
immunemedi
mening
although
sign
refer
joint
inflamm
almost
alway
mask
sign
mening
except
akita
puppi
dougherti
et
al
mening
polyarthr
clinic
appar
famili
mediterranean
fever
famili
mediterranean
fever
human
disord
character
recurr
fever
unknown
origin
renal
amyloidosi
evid
periton
pleuriti
andor
synov
syndrom
thought
similar
famili
mediterranean
fever
describ
chines
sharpei
dog
riva
et
al
whether
syndrom
human
disord
remain
determin
diseas
dog
show
elev
level
serum
hypergammaglobulinemia
compar
normal
control
affect
dog
two
year
old
older
frequent
suffer
renal
failur
associ
amyloidosi
swollen
joint
juvenil
cellul
arthriti
four
dog
diagnos
juvenil
cellul
juvenil
pyoderma
puppi
strangl
sign
joint
pain
addit
characterist
facial
inflamm
submandibular
lymphadenopathi
white
et
al
synovi
fluid
three
four
dog
joint
pain
reveal
suppur
arthriti
neg
bacteri
growth
cultur
concurr
treatment
antibiot
prednison
highli
effect
cure
facial
joint
lesion
nondeform
arthriti
associ
neoplasia
steril
polyarthr
observ
dog
cat
overt
latent
neoplast
process
part
bodi
pedersen
et
al
bennett
sign
polyarthr
may
preced
sign
cancer
may
minor
major
compon
overal
diseas
syndrom
enteropath
arthriti
enteropath
arthriti
frequent
associ
diseas
like
ulcer
coliti
region
enter
man
caus
arthriti
unknown
thought
either
bowel
joint
diseas
share
common
etiolog
antigen
product
releas
blood
inflam
bowel
effect
synovium
hepatopath
arthropathi
seen
sever
dog
chronic
activ
hepat
cirrhosi
also
type
enteropath
arthriti
diseas
antigen
materi
bowel
probabl
gain
access
gener
bloodstream
remov
portal
blood
reticuloendotheli
tissu
liver
polyarthr
dog
ulcer
coliti
fulmin
enterocol
recogn
pedersen
et
al
addit
small
percentag
dog
idiopath
polyarthr
problem
flatul
occasion
vomit
eventu
gastric
torsion
latter
indic
degre
preexist
motil
problem
plasmacyticlymphocyt
goniti
synov
observ
less
dog
oper
cranial
cruciat
ligament
ccl
ruptur
subclass
dog
tend
younger
usual
dog
ccl
ruptur
often
purebr
anim
mediums
breed
rottweil
lead
pronounc
joint
laxiti
instabl
often
manifest
cruciat
ligament
damag
instabl
synovium
grossli
thicken
edemat
reddishyellowish
ting
synovi
fluid
cloudi
less
viscou
yellow
ting
contain
white
cell
per
ml
neutrophil
unlik
inflammatori
joint
diseas
predomin
cell
often
small
lymphocyt
fluid
steril
known
microorgan
radiograph
chang
present
minim
includ
soft
tissu
swell
periost
prolif
chang
eros
chang
absent
slight
featur
may
relat
preexist
instabl
due
ligament
weak
synovi
biopsi
show
intens
lymphocyticplasmacyt
infiltr
synovi
hypertrophi
sometim
villou
subchondr
eros
minim
absent
etiolog
disord
unknown
still
uncertain
whether
peculiar
synov
lead
cruciat
ligament
laxityruptur
whether
mere
secondari
immun
reaction
host
degener
ligament
favor
latter
etiolog
ccl
reconstruct
often
cur
dog
significantli
increas
level
serum
antin
collagen
type
ii
antibodi
assess
elisa
also
measur
dog
divers
joint
diseas
rheumatoid
arthriti
infect
arthriti
primari
djd
ccl
ruptur
bari
et
al
favor
cruciat
diseas
secondari
immun
disord
proper
immunosuppress
drug
therapi
earli
cours
diseas
often
render
affect
anim
sound
subset
dog
form
ccl
ruptur
differ
older
sedentari
overweight
spay
femal
dog
develop
classic
ligament
degener
breed
dog
suffer
disord
tend
breed
afflict
immunolog
diseas
inflamm
sometim
detect
joint
affect
stifl
regardless
ultim
caus
would
prudent
treat
atyp
case
ccl
ruptur
inflammatori
synovi
fluid
medic
earli
diseas
cours
possibl
augment
substitut
medic
treatment
surgeri
advanc
case
anim
fail
respond
medic
medic
treatment
would
immunolog
arthritid
druginduc
arthriti
druginduc
vasculitid
usual
manifest
acut
skin
joint
involv
becom
increasingli
common
dog
especi
proport
purebr
anim
increas
cribb
giger
et
al
grondalen
harvey
common
drug
hypersensit
sulfonamid
although
author
observ
ident
diseas
use
penicillin
erythromycin
lincomycin
cephalosporin
drug
reaction
involv
deposit
drugantibodi
complex
around
blood
vessel
differ
area
bodi
drug
may
act
directli
antigen
may
combin
host
protein
hapten
form
neoantigen
polyarthr
one
featur
diseas
syndrom
fever
lymphadenopathi
variou
type
macularpapular
bullou
type
hemorrhag
rash
frequent
accompani
diseas
joint
fluid
contain
larg
number
nondegen
neutrophil
first
sign
allerg
reaction
tend
occur
day
drug
treatment
initi
condit
time
period
sensit
occur
altern
drug
reaction
may
occur
within
hour
administ
drug
use
safe
past
affect
dog
becom
acut
febril
stiff
sore
develop
gener
rash
rash
take
sever
form
individu
lesion
skin
clearli
vascular
origin
hemorrhag
blister
focal
necrosi
hemorrhag
sever
focal
petechi
etc
addit
featur
may
includ
lymphadenopathi
polymyos
anemia
glomerulonephr
focal
retin
leukopenia
thrombocytopenia
diagnosi
readili
appar
provid
clinician
astut
enough
connect
drug
treatment
onset
acut
vascul
syndrom
involv
primarili
skin
joint
linkag
may
miss
especi
assum
condit
hand
mere
extens
condit
treatment
prescrib
rapid
resolut
sign
upon
discontinu
drug
treatment
although
whirlpool
bath
glucocorticoid
may
requir
speed
heal
skin
lesion
treatment
immunemedi
arthritid
first
imper
determin
whether
arthriti
associ
signific
underli
diseas
process
incit
diseas
present
treatment
concentr
underli
caus
first
immun
arthriti
second
object
therapi
complet
remiss
correl
disappear
synovi
fluid
abnorm
return
percept
outward
normalci
allow
joint
diseas
slowli
simmer
inadequ
treatment
lead
secondari
djd
period
month
year
moreov
accept
less
complet
remiss
anim
unkind
even
greater
clinic
improv
expect
total
control
import
use
synovi
fluid
analysi
determin
complet
remiss
achiev
dog
may
return
near
clinic
normalci
treatment
yet
still
demonstr
mild
synovi
inflamm
lowgrad
inflamm
allow
persist
djd
gradual
occur
complic
overal
clinic
pictur
prudent
therefor
select
sever
joint
initi
show
inflammatori
chang
reexamin
fluid
joint
period
drug
therapi
clinic
accept
reduct
joint
inflamm
achiev
glucocorticoid
alon
onethird
case
higher
percentag
treat
glucocorticoid
alon
dosag
kept
high
therapi
continu
long
period
time
sideeffect
longterm
highdos
therapi
great
howev
combin
drug
therapi
prefer
drug
therapi
drastic
chang
clinic
appear
lame
immedi
reevalu
statu
joint
diseas
imper
author
seen
dog
develop
sever
septic
arthriti
month
treat
immunemedi
arthriti
undiagnos
underli
endocard
pyelonephr
grave
mistak
reinstitut
intensifi
drug
therapi
presumpt
disord
immunemedi
mening
increasingli
common
disord
dog
condit
also
call
periarter
nodosa
resembl
kawasaki
syndrom
human
tipold
et
al
particularli
common
adolesc
young
adult
beagl
pointer
boxer
akita
weimeran
bernes
mountain
dog
uncommon
mongrel
sever
chronic
diseas
vari
among
breed
clinic
sign
beagl
pointer
weimeran
boxer
consist
cyclic
bout
fever
sever
neck
pain
rigid
reluct
move
depress
albassam
et
al
hay
et
al
poncelet
balligand
ruben
et
al
snyder
et
al
spencer
greav
attack
last
day
interven
period
complet
partial
normalci
last
week
cerebr
spinal
fluid
collect
attack
elev
protein
neutrophil
content
fluid
taken
attack
normal
caus
lesion
beagl
probabl
breed
well
arter
mening
vessel
occasion
tissu
well
eg
synovium
diseas
often
selflimit
sever
month
attack
becom
milder
longer
interv
glucocorticoid
therapi
help
minim
sever
attack
sever
form
immunemedi
mening
seen
young
bernes
mountain
dog
diseas
bernes
mountain
dog
somewhat
cyclic
incomplet
resolut
interven
period
cerebrospin
fluid
abnorm
resembl
diseas
breed
condit
less
like
selflimit
breed
often
requir
longterm
high
dose
glucocorticoid
therapi
maintain
anim
comfort
state
syndrom
mening
usual
associ
polyarthr
seen
akita
young
week
age
dougherti
et
al
anim
show
sever
somewhat
cyclic
bout
fever
depress
cervic
pain
rigid
gener
stiff
affect
anim
grow
slower
rate
often
appear
unthrifti
condit
respond
poorli
glucocorticoid
combin
immunosuppress
therapi
anim
euthanit
earli
adult
milder
drug
respons
form
diseas
seen
older
akita
condit
older
akita
may
associ
pemphigu
foliac
uveiti
plasmacyt
lymphocyt
thyroid
immunemedi
renal
diseas
linear
deposit
immun
complex
goodpastur
diseas
human
manifest
immunemedi
glomerulonephr
nephrot
syndrom
pulmonari
hemorrhag
glomerular
lesion
associ
bind
antiglomerular
basement
membran
antibodi
glomerular
basement
membran
linear
type
antibodi
deposit
seen
ifa
pulmonari
lesion
associ
breakdown
alveoli
associ
deposit
antibodi
alveolar
basement
membran
singl
dog
condit
histolog
clinic
resembl
goodpastur
diseas
recogn
lumpybumpi
deposit
immun
complex
glomerulonephr
associ
granular
lumpybumpi
immun
complex
deposit
common
immun
complex
disord
anim
exist
sever
histopatholog
form
either
primari
idiopath
secondari
natur
lesion
result
irregular
deposit
immunoglobulin
complement
subepitheli
subendotheli
side
glomerular
basement
membran
lumpybumpi
deposit
consist
circul
preform
immun
complex
rather
situ
antibas
membran
react
antibodi
glomerulonephr
either
sole
primari
manifest
idiopath
glomerulonephr
secondari
featur
immunecomplex
gener
disord
dog
secondari
glomerulonephr
almost
alway
present
sign
overli
diseas
kidney
problem
diagnos
secondarili
glomerulonephr
describ
secondari
chronic
infecti
diseas
babesiosi
wozniak
et
al
infecti
canin
hepat
hervaa
et
al
dirofilariasi
nakagaki
et
al
ehrlichiosi
codner
et
al
leishmaniasi
nieto
et
al
poli
et
al
bacteri
endocard
macdougal
et
al
noninfecti
condit
chronic
congenit
portosystem
shunt
tisdal
et
al
congenit
complement
defici
ameratunga
et
al
blum
et
al
dog
idiopath
glomerulonephr
present
mainli
sign
kidney
diseas
human
juvenil
adultonset
form
diseas
occur
dog
juvenil
nephropathi
report
dalmatian
dixon
famili
glomerulopathi
associ
membranoprolif
glomerul
interstiti
nephriti
observ
bernes
mountain
dog
minku
et
al
reusch
et
al
b
dambach
et
al
describ
case
rapidli
progress
highli
fatal
glomerulonephr
dog
affect
anim
younger
ae
year
dog
idiopath
glomerulonephr
ae
year
labrador
golden
retriev
five
time
repres
glomerular
diseas
mainli
membranoprolif
associ
subendotheli
igg
igm
deposit
although
diseas
link
lyme
borreliosi
exposur
vaccin
silver
stain
fail
show
strong
relationship
spirochet
kidney
lesion
develop
mani
dog
glomerulonephr
present
nephrot
triad
proteinuria
hypoproteinemia
peripher
edema
glomerular
diseas
signific
also
concomit
loss
nephron
sign
renal
failur
elev
serum
creatinin
azotemia
isosthenuria
polyuriapolydypsia
dog
glomerulonephr
nephrot
syndrom
often
hypercoagul
due
renal
loss
anticoagul
elev
serum
fibrinogen
sudden
death
due
thrombosi
pulmonari
arteri
seriou
problem
anim
dog
secondari
glomerulonephr
almost
alway
present
sign
overli
ill
glomerular
diseas
detect
incident
find
clinic
workup
postmortem
examin
diagnosi
glomerulonephr
made
basi
clinic
sign
weight
loss
peripher
edema
polyuriapolydypsia
laboratori
find
hypoproteinemia
hyperproteinuria
confirm
renal
biopsi
glomerular
chang
classifi
case
convent
light
microscopi
pattern
immun
complex
deposit
determin
immunofluorescen
immunoperoxidas
stain
human
categori
glomerular
diseas
observ
dog
ie
focal
diffus
mesangi
prolif
diffus
endocapillari
prolif
mesangiocapillari
diffus
crescent
diffus
scleros
amyloid
unclassifi
macdougal
et
al
immun
complex
consist
igg
igm
minku
et
al
iga
harri
et
al
miyauchi
et
al
combin
three
complement
igg
apt
associ
dens
deposit
iga
igm
observ
anim
dens
minim
deposit
koeman
et
al
membran
mesangi
prolif
chang
vari
sever
except
case
lesion
unappar
upon
light
microscop
examin
may
even
minim
view
electron
microscopi
vilafranca
et
al
latter
dog
condit
analog
minim
chang
diseas
human
overli
underli
diseas
condit
emphasi
place
treat
diseas
debat
whether
dog
gn
treat
conserv
low
protein
diet
blood
pressur
control
lulich
et
al
vigor
addit
immunosuppress
drug
conserv
therapi
often
favor
rel
high
incid
spontan
remiss
biewenga
gruy
poor
respons
sideeffect
prolong
immunosuppress
drug
therapi
cyclosporin
treatment
found
offer
improv
nontreat
anim
treatment
glomerulonephr
associ
number
sideeffect
vaden
et
al
question
dog
especi
younger
anim
minim
glomerular
chang
acut
onset
nephrot
syndrom
selfcur
sever
month
conserv
treatment
diet
chang
without
glucocorticoid
howev
diseas
dog
selfcur
vigor
treatment
slow
cours
renal
diseas
glucocorticoid
alon
usual
effect
combin
therapi
glucocorticoid
cytotox
drug
cyclophosphamid
azathioprin
requir
unfortun
dog
glomerulonephr
present
late
diseas
cours
treatment
minim
effect
mean
surviv
one
larg
group
dog
glomerular
diseas
glomerulonephr
renal
amyloidosi
day
cook
cowgil
amyloidosi
technic
immun
complex
diseas
fit
origin
gel
coomb
classif
scheme
amyloidosi
occur
condit
immunemedi
glomerulonephr
idiopath
secondari
chronic
antigen
stimul
diseas
chronic
inflammatori
diseas
chronic
infecti
diseas
macintir
et
al
immun
diseas
rheumatoid
arthriti
juvenil
polyarter
snyder
et
al
dermatomyos
hargi
et
al
congenit
complement
defici
blum
et
al
neoplasia
geisel
et
al
platz
et
al
senil
shimada
et
al
shimada
et
al
uchida
et
al
uchida
et
al
genet
may
play
import
role
idiopath
amyloidosi
describ
chines
shar
pei
dog
dibartola
et
al
dubui
et
al
loeven
riva
et
al
beagl
bowl
mosier
english
foxhound
mason
day
amyloid
complex
pleat
protein
sever
differ
serum
compon
contribut
makeup
sellar
et
al
case
amyloid
consist
mainli
reaggreg
variabl
region
immunoglobulin
light
chain
condit
associ
increas
product
catabol
immunoglobulin
therefor
like
associ
form
amyloid
amyloidlight
chain
al
intact
immunoglobulin
light
chain
convert
amyloid
fibril
known
may
involv
catabol
immunoglobulin
immunoglobulin
subunit
macrophag
amyloid
also
made
nonimmunoglobulin
protein
socal
amyloid
unknown
origin
amyloid
aa
small
proport
al
aa
consist
plasma
compon
relat
globulin
amyloidosi
man
anim
classifi
either
primari
idiopath
secondari
chronic
infecti
diseas
immunolog
diseas
neoplasia
senil
tendenc
howev
classifi
amyloidosi
man
accord
chemic
composit
amyloid
follow
classif
use
man
appear
similar
anim
clinic
amyloidosi
dog
usual
involv
kidney
beta
amyloidosi
brain
age
dog
describ
less
commonli
weegiel
et
al
renal
amyloidosi
associ
heavi
proteinuria
nephrot
syndrom
eventu
renal
failur
like
glomerulonephr
primari
form
renal
amyloidosi
present
mainli
nephrot
syndrom
secondari
form
often
associ
underli
overli
diseas
syndrom
variou
glomerulopathi
dog
amyloidosi
membran
glomerulonephr
like
associ
nephrot
syndrom
azotemia
hypercoagul
thrombot
disord
biewenga
gruy
cook
cowgil
secondari
primari
caus
correct
revers
sign
may
occur
sever
dog
idiopath
renal
amyloidosi
treat
dmso
oral
substanc
taken
blood
secret
kidney
object
dissolv
amyloid
deposit
prevent
amyloid
deposit
spyridaki
et
al
howev
hard
get
anim
ingest
suffici
quantiti
heavi
garlic
odor
dmso
treatment
alway
effect
appear
prolong
surviv
rather
cure
diseas
overal
renal
amyloidisi
dog
carri
poor
prognosi
mean
surviv
time
less
one
month
cook
cowgil
dermatomyos
describ
colli
shelti
collielabrador
retriev
cross
hargi
et
al
cutan
muscular
vascular
lesion
note
juvenil
adult
anim
gross
lesion
sever
head
distal
extrem
microscop
lesion
includ
myositi
esophag
musculatur
arter
skin
muscl
bladder
spermat
cord
lymphoid
hyperplasia
especi
peripher
node
mild
lymphocyt
thyroid
cellmedi
immun
mediat
two
cell
type
lymphocyt
macrophag
evolutionari
step
phagocytosi
humor
immun
natur
killer
nk
cell
appear
first
follow
thereaft
specif
thymusderiv
lymphocyt
tcell
cellmedi
immun
function
mainli
bodi
cell
render
foreign
either
malign
transform
intracellular
microorgan
invas
cell
individu
allogen
cell
differ
xenogen
speci
nk
cell
subpopul
lymphocyt
bear
neither
tor
bcell
marker
henc
altern
name
null
cell
nk
cell
activ
rest
within
larg
granular
popul
blood
lymphocyt
nk
cell
primit
receptor
surfac
nonspecif
identifi
mani
type
antigen
alter
host
cell
malign
cell
infect
cell
singl
nk
cell
recogn
wide
spectrum
abnorm
cell
nk
cell
immun
antigen
specif
therefor
nk
cell
activ
consid
integr
part
innat
rather
adapt
immun
vitro
assay
procedur
nk
cell
activ
involv
kill
tumor
cell
target
nk
cell
recogn
foreign
alter
cell
wander
bodi
cell
capabl
recogn
wide
rang
abnorm
cell
nk
cell
touch
membran
abnorm
cell
kill
releas
specif
lymphokin
nk
cellmedi
kill
enhanc
antibodi
specif
abnorm
surfac
antigen
malign
antigen
alter
cell
process
known
antibodi
depend
cellular
cytotox
adcc
exampl
primit
form
immun
upgrad
subsequ
evolut
antigen
specif
humor
immun
tcell
evolv
cellmedi
immun
also
use
later
control
regul
bcell
immun
tcellmedi
immun
mediat
two
subclass
cell
bear
cell
surfac
antigen
possess
cell
surfac
antigen
tcell
help
bcell
produc
antibodi
often
refer
helper
cell
also
import
gener
mainten
immunolog
memori
tcell
function
suppress
bcell
activ
call
suppressor
cell
cell
also
import
effector
adapt
cellmedi
immun
tcell
evolv
immunoglobulinlik
receptor
surfac
unlik
nk
cell
tcell
possess
receptor
singl
antigen
epitop
therefor
hundr
thousand
antigen
specif
tcell
subpopul
exist
bodi
bcell
humor
immun
first
appear
higher
fish
natur
evolutionari
step
tcell
immun
tcell
immun
immunoglobulinlik
receptor
firmli
anchor
cell
surfac
bcell
immun
receptor
also
excret
free
surround
bodi
fluid
antibodi
tcellmedi
cytotox
trigger
cell
surfac
antigen
either
foreign
allogen
xenogen
alter
host
cell
recogn
correspond
antigen
specif
tcell
initi
recognit
lead
elabor
numer
lymphokin
cytokin
lymphokin
may
nonspecif
antimicrobi
activ
interferon
cytokin
induc
clonal
expans
subpopul
tcell
bear
ident
antigen
receptor
prolifer
tcell
becom
antigenspecif
effector
killer
cell
teffector
cell
recogn
kill
abnorm
cell
bring
intim
contact
releas
cytotox
lymphokin
macrophag
favorit
reservoir
microbi
growth
ingest
organ
part
phagocyt
function
import
target
tcell
respons
teffector
cell
either
kill
infect
macrophag
directli
activ
surround
macrophag
assist
direct
cell
kill
instruct
macrophag
activ
destroy
microb
might
contain
latter
two
process
import
intracellular
infect
virus
latter
import
macrophag
contain
complex
microb
bacteria
protozoa
parasit
fungi
host
cell
render
foreign
specif
foreign
antigen
elabor
surfac
thu
render
target
attack
specif
tcell
activ
macrophag
malign
cell
may
express
new
antigen
surfac
antigen
may
uniqu
bodi
express
embryogenesi
prior
time
selftoler
induc
cell
infect
microb
also
render
foreign
foreign
protein
produc
within
cell
microb
transport
cell
surfac
express
major
histocompat
complexi
mhci
host
cell
may
also
render
foreign
surfac
antigen
chemic
alter
case
contact
hypersensit
plastic
drug
substanc
rare
case
normal
cell
come
attack
killer
tcell
mechan
ident
describ
autoantibodi
respons
wucherpfennig
et
al
variou
mechan
ampli
illustr
number
varieti
immun
disord
dog
type
iv
immun
etiolog
flea
allerg
dermat
interest
immedi
intermedi
delay
hypersensit
reaction
occur
anim
fact
evolut
one
type
immun
demonstr
anim
almost
four
decad
ago
benjamini
et
al
immedi
reaction
character
reaction
appear
within
min
antigen
challeng
wherea
delay
hypersensit
reaction
take
h
reach
peak
intens
former
reaction
character
edema
neutrophil
eosinophil
infiltr
latter
inflamm
mononuclear
cell
lymphocyt
macrophag
plasma
cell
infiltr
poison
oak
poison
ivi
classic
exampl
delay
hypersensit
reaction
human
oil
plant
chemic
combin
epiderm
protein
result
format
neoantigen
sensit
peopl
alter
protein
occur
initi
exposur
subsequ
exposur
lead
rapid
influx
lymphocyt
macrophag
sensit
skin
result
delay
hypersensit
reaction
essenti
attempt
reject
one
skin
fortun
dog
sensit
plant
sensit
analog
poison
oak
ivi
observ
dog
case
muzzl
hypersensit
associ
eat
plastic
food
dish
resin
present
plastic
leach
food
bind
skin
muzzl
granulomat
reaction
occur
respons
number
intracellular
infecti
agent
tuberculosi
coccidioidomycosi
histoplasmosi
etc
essenti
delayedtyp
hypersensit
reaction
result
howev
partial
cellular
immun
complet
cellular
immun
result
effect
activ
macrophag
destruct
inactiv
intracellular
organ
complet
failur
cellular
immun
lead
widespread
dissemin
organ
littl
attempt
host
contain
infect
case
partial
cellular
immun
contain
organ
incomplet
manifest
granuloma
format
juvenil
pyoderma
pronounc
submandibular
cervic
lymphadenopathi
edema
pustul
format
muzzl
white
et
al
occur
exclus
puppi
especi
brittani
spaniel
dachshund
pointer
breed
juvenil
pyoderma
usual
associ
facial
staphylococc
pyoderma
howev
condit
seem
result
inappropri
cellular
immun
respons
staphylococc
infect
treat
antibiot
prednisolon
dog
get
older
immun
respons
becom
normal
flamboy
respons
seen
form
precis
etiolog
unknown
diseas
process
type
iv
natur
direct
antigen
within
joint
whether
antigen
host
origin
yet
unknown
agent
unknown
dens
mixedinflammatori
reaction
center
synovi
membran
subchondr
bone
cartilag
undermin
subchondr
inflamm
overlain
pannu
granul
tissu
eman
point
synovi
attach
net
effect
progress
destruct
cartilag
start
joint
margin
ultim
lead
joint
instabl
sublux
luxat
synovi
membran
undergo
characterist
villu
hyperplasia
dens
infiltr
plasma
cell
lymphocyt
lymphocyt
infiltr
human
diseas
result
almost
clonal
expans
select
tcell
autoreact
lack
function
import
surfac
marker
marten
et
al
howev
role
cell
pathogenesi
etiolog
human
ra
unknown
breedveld
inflammatori
chang
observ
ra
appear
cytokin
produc
macrophagemonocyt
tcell
smolen
et
al
rheumatoid
factor
hallmark
human
ra
rheumatoid
factor
autoantibodi
usual
igm
reactiv
immun
complex
ig
rheumatoid
factor
present
high
titer
human
ra
also
detect
patient
wide
rang
chronic
infect
rheumatoid
factor
pathogen
passiv
transfer
high
titer
serum
induc
arthriti
possibl
howev
immun
complex
contain
rheumatoid
factor
contribut
diseas
type
iii
mechan
canin
rheumatoid
arthriti
welldocu
clinic
entiti
halliwel
et
al
liu
et
al
newton
et
al
pedersen
et
al
although
uncommon
compar
noneros
arthritid
incid
approxim
two
per
dog
examin
author
hospit
significantli
less
frequenc
ra
peopl
disord
occur
mainli
small
toy
breed
dog
young
eight
month
old
eight
year
age
although
rheumatoid
arthriti
categor
eros
polyarthr
discuss
clinician
part
world
often
lump
noneros
polyarthr
rheumatoid
arthriti
author
opinion
unjustifi
clear
histopatholog
radiograph
clinic
differ
two
type
diseas
canin
rheumatoid
arthriti
manifest
initi
shift
lame
soft
tissu
swell
around
involv
joint
within
sever
week
month
diseas
local
particular
joint
characterist
radiograph
sign
develop
joint
involv
sever
carpal
tarsal
joint
although
individu
dog
elbow
stifl
shoulder
hip
joint
may
show
similar
radiograph
sign
involv
apophys
joint
costovertebr
articul
rare
progress
point
caus
radiograph
chang
except
case
howev
involv
vertebr
articul
occur
diseas
often
accompani
fever
malais
anorexia
lymphadenopathi
earlier
stage
renal
amyloidosi
complic
longstand
diseas
inadequ
control
colbatzki
et
al
earliest
radiograph
chang
consist
soft
tissu
swell
loss
trabecular
bone
densiti
area
joint
lucent
cystlik
area
frequent
seen
subchondr
bone
promin
lesion
progress
destruct
subchondr
bone
central
area
well
margin
attach
synovium
pedersen
et
al
narrow
widen
joint
space
identifi
radiograph
result
cartilag
eros
destruct
subchondr
bone
sublux
luxat
deform
occur
frequent
carpal
tarsal
phalang
joint
occasion
elbow
stifl
joint
fibrou
ankylosi
occur
advanc
case
particularli
intercarp
intertars
joint
space
hemogram
either
normal
reflect
gener
inflammatori
process
leukocytosi
neutrophilia
hyperfibrinogenemia
pedersen
et
al
serum
electrophoresi
often
show
hypoalbuminemia
variabl
elev
gglobulin
rheumatoid
factor
ie
autoantibodi
steric
alter
eg
immun
complex
antibodi
hallmark
human
rheumatoid
arthriti
present
high
titer
threefourth
affect
peopl
rheumatoid
factor
probabl
serv
function
crosslink
immun
complex
aid
clearanc
phagocyt
detect
therefor
mani
diseas
chronic
immun
complex
occur
although
definit
valu
diagnosi
human
rheumatoid
arthriti
valu
rheumatoid
factor
test
canin
rheumatoid
arthriti
less
certain
veterinari
research
abl
detect
rheumatoid
factor
major
affect
dog
small
proport
normal
dog
anim
condit
bennett
kirkham
one
studi
howev
rheumatoid
factor
detect
compar
low
titer
one
quarter
case
canin
rheumatoid
arthriti
pedersen
et
al
recent
studi
also
confirm
rheumatoid
factor
present
low
titer
onefourth
dog
rheumatoid
arthriti
also
present
similar
titer
incid
unclassifi
polyarthr
heartworm
diseas
pyometra
leishmaniasi
system
lupu
erythematosu
sle
chabann
et
al
nielsen
antinuclear
antibodi
sometim
detect
dog
rheumatoid
arthriti
frequent
sle
synovi
fluid
chang
indic
inflammatori
synov
elev
total
cell
count
high
proport
neutrophil
synovi
fluid
cell
popul
variabl
decreas
qualiti
mucin
clot
ragocyt
neutrophil
ingest
immun
complex
describ
human
rheumatoid
arthriti
usual
seen
characterist
find
canin
rheumatoid
arthriti
presenc
synovi
fluid
mononuclear
cell
contain
igg
occasion
cell
contain
protein
pedersen
et
al
mononuclear
cell
may
produc
immunoglobulin
ingest
synovi
fluid
characterist
patholog
lesion
consist
villou
hyperplasia
synovi
membran
lymphoid
plasma
cell
infiltr
synovium
infiltr
cell
destroy
articular
cartilag
start
margin
joint
pannu
granul
tissu
also
invad
surfac
cartilag
central
region
joint
cartilag
destruct
caus
pannu
aris
granul
tissu
underli
marrow
caviti
ankylosi
advanc
lesion
uncommon
intercarp
intertars
joint
dens
lymphoid
plasma
cell
infiltr
synovium
destruct
articular
cartilag
differenti
rheumatoid
arthriti
synov
seen
noneros
type
arthriti
presenc
larg
number
lymphocyt
plasma
cell
synovium
suggest
presenc
local
antigen
stimulu
type
iv
delayedtyp
hypersensit
reaction
natur
antigen
evok
reaction
unknown
canin
rheumatoid
arthriti
respond
temporarili
system
corticosteroid
aspirin
appreci
therapeut
benefit
author
hand
probabl
diseas
much
sever
rapidli
progress
dog
man
condit
recogn
sever
joint
damag
occur
usual
arrest
combin
immunosuppress
drug
therapi
type
therapi
cover
detail
discuss
drug
therapi
immunemedi
arthritid
dog
advanc
deform
immunosuppress
drug
therapi
may
combin
arthrodesi
select
joint
arthrodesi
warrant
diseas
process
first
success
halt
drug
therapi
semieros
polyarthr
greyhound
occur
differ
part
world
castelli
huxtabl
davi
woodard
et
al
diseas
appear
anim
month
age
frequent
attack
proxim
interphalang
carpal
tarsal
elbow
stifl
joint
shoulder
hip
atlantooccipit
joint
less
frequent
involv
tenosynov
may
accompani
featur
synovi
membran
edemat
hyperem
earli
cours
diseas
may
cover
fine
layer
fibrin
synovi
fluid
cloudi
yellowish
often
contain
fibrin
tag
later
stage
lymphocyt
plasma
cell
infiltr
seen
synovi
line
peripher
lymph
node
enlarg
hyperact
pannu
format
margin
subchondr
eros
seen
limit
extent
destruct
articular
cartilag
occur
joint
often
associ
pannu
format
gross
deform
radiograph
chang
appar
seen
canin
rheumatoid
arthriti
appear
pronounc
describ
noneros
joint
diseas
mycoplasm
bacteri
isol
usual
unsuccess
dog
serolog
neg
erysipelothrix
chlamydia
howev
mycoplasma
spuman
isol
young
greyhound
polyarthr
signific
singl
isol
polyarthr
greyhound
remain
determin
number
glandular
disord
man
anim
appear
involv
immun
phenomena
alway
clear
whether
immunolog
abnorm
caus
effect
lymphocyt
thyroid
adren
parathyroid
type
diabet
mellitu
endocrin
disord
relat
way
autoimmun
dog
greco
harpold
immun
phenomena
also
involv
kerat
sicca
perian
fistula
sebac
gland
aden
lymphocyticplasmacyt
thyroid
hypothyroid
undoubtedli
common
endocrin
disord
dog
disord
caus
equal
proport
lymphocyticplasmacyt
thyroid
idiopath
atrophi
kemppainen
clark
former
analog
hashimoto
thyroid
man
appear
autoimmun
origin
thyroid
atrophi
may
separ
entiti
rather
end
stage
thyroid
hypothyroid
dog
one
studi
lymphocyt
thyroid
biopsi
nachrein
et
al
thyroid
also
shown
progress
sever
atrophi
studi
hypothyroid
beagl
benjamin
et
al
human
hypothyroid
underli
signific
proport
immun
disord
dog
seen
overwhelmingli
purebr
breed
suffer
hypothyroid
includ
golden
retreiv
beagl
doberman
pinshcer
akita
cocker
spaniel
rottweil
among
breed
suffer
rang
immun
disord
addit
common
find
lymphocyt
infiltr
fibrosi
atrophi
mani
dog
hypothyroid
detect
antithyroid
antibodi
human
hashimoto
diseas
antibodi
usual
thyroid
peroxidas
howev
appear
case
dog
thacker
et
al
rather
dog
lymphocyt
thyroid
develop
antibodi
thyroglobulin
vari
degre
nachrein
et
al
antibodi
thyroglobulin
occur
predominantli
subclass
day
b
c
clinic
sign
hypothyroid
affect
dog
order
frequenc
obes
seborrhea
alopecia
weak
lethargi
bradycardia
pyoderma
panciera
neurolog
disord
jaggi
et
al
b
jaggi
oliv
reproduct
failur
johnson
also
associ
hypothyroid
dog
diagnosi
thyroid
hypothyroid
take
account
clinic
sign
breed
predisposit
evid
decreas
level
triiodothyronin
thyroxin
increas
level
tsh
presenc
antibodi
thyoglobulin
clinic
research
feel
posttsh
stimul
level
singl
diagnost
test
jaggi
oliv
presenc
autoantibodi
caus
serum
concentr
appear
fals
high
howev
free
nondetect
measur
dialysi
assay
kemppainen
et
al
compar
studi
sever
test
demonstr
serum
free
tsh
concentr
use
reach
diagnosi
although
free
test
highli
sensit
greater
specif
obtain
combin
two
assay
tsh
test
although
specif
lack
sensit
onefourth
hypothyroid
dog
valu
normal
refer
rang
antibodi
assay
thyroglobulin
also
found
sensit
specif
diagnos
dog
lymphocyt
thyroid
compar
antibodi
test
andor
nachrein
et
al
dog
hypothyroid
usual
treat
lthyroxin
usual
bring
resolut
clinic
sign
diseas
parathyroid
hypoparathyroid
parathyroid
gland
biopsi
taken
dog
acquir
hypoparathyroid
often
demonstr
chang
similar
observ
dog
thyroid
adren
gland
dog
hypothyroid
addison
diseas
lymphocyt
adren
associ
adren
atrophi
dog
hypoadrenocortico
sadek
schaer
diseas
occur
often
purebr
distinct
predisposit
standard
poodl
leonberg
smallwood
barsanti
treatment
choic
hormon
replac
therapi
especi
desoxycorticosteron
pival
kintzer
peterson
vanzyl
hyman
polyglandular
syndrom
multipl
endocrin
disord
immun
natur
describ
dog
addison
diseas
associ
megaesophagu
similar
allgrov
syndrom
peopl
describ
german
shepherd
dog
fritzen
et
al
boxer
dog
hypothyroid
addison
diseas
also
report
kooistra
et
al
two
four
leonberg
hypoadrenocortico
also
found
hypothyroid
smallwood
barsanti
combin
adrenaland
thyroidinsuffici
known
type
ii
polyglandular
autoimmun
schmidt
syndrom
human
insulin
depend
type
diabet
mellitu
insulin
depend
type
diabet
mellitu
human
polygen
autoimmun
diseas
character
infiltr
islet
langerhan
activ
lymphocyt
product
islet
cell
antibodi
eli
hoenig
type
diabet
mellitu
also
common
diseas
dog
may
spontan
occur
model
human
disord
greco
harpold
saei
gouin
kerat
sicca
kerat
sicca
refer
corneal
infect
occur
secondari
inadequ
tear
format
ultim
caus
diseas
lacrim
gland
either
canin
distemp
viru
infect
radiat
damag
drug
reaction
maje
et
al
immunereact
immunemedi
lacrim
gland
inflamm
type
iv
natur
occur
frequent
dog
often
purebr
select
toward
cocker
spaniel
latter
condit
dog
sometim
refer
sjo
syndrom
human
disord
associ
immun
destruct
salivari
gland
rheumatoidlik
arthriti
applic
term
canin
condit
prematur
prognosi
kerat
sicca
depend
underli
caus
anim
chronic
drug
therapi
especi
sulfa
condit
medic
discontinu
howev
perman
damag
may
alreadi
occur
frequent
applic
artifici
tear
topic
antibiot
usual
requir
long
tear
product
inadequ
opportunist
fungal
infect
must
consid
case
infect
respond
antibiot
smede
et
al
case
immunemedi
diseas
common
caus
kerat
sicca
dog
treatment
choic
cyclosporin
eye
drop
bring
rapid
remiss
major
case
sebac
aden
sebac
aden
diseas
recogn
predominantli
akita
standard
poodl
white
et
al
diseas
manifest
scale
alopecia
secondari
pyoderma
target
disord
sebac
gland
inflamm
mainli
lymphocyticplasmacyt
type
earlier
report
diseas
describ
use
isotretinoin
etretin
onehalf
dog
greater
improv
white
et
al
treatment
choic
howev
appear
leflunomid
combin
glucocorticoid
perian
aden
perian
fistula
inflamm
circuman
apocrin
sweat
gland
lead
sever
perian
fistula
occur
predominantli
german
shepherd
dog
lesser
degre
irish
setter
killingsworth
et
al
incid
higher
male
femal
greater
intact
compar
neuter
anim
perian
abnorm
associ
histolog
evid
coliti
well
harkin
et
al
perian
lesion
vari
greatli
even
dog
degre
fibrosi
sever
inflammatori
respons
depth
sinu
tract
killingsworth
et
al
lesion
tend
zona
cutanea
hidraden
format
epitheliallin
sinu
tract
appar
onehalf
biopsi
examin
anoth
studi
deal
anatom
predisposit
predispos
caus
german
shepherd
nonaffect
breed
greater
number
apocrin
sweat
gland
zona
cuneata
budsberg
et
al
secondari
bacteri
infect
number
differ
bacteria
inevit
present
killingsworth
et
al
immunolog
natur
diseas
discov
treatment
choic
often
surgic
excis
fistul
tissu
glucocorticoid
special
diet
ellison
harkin
et
al
holt
viehoff
van
sluji
accept
treatment
cyclosporin
syndrom
specif
genet
disord
manifest
bilater
uveiti
mening
depig
skin
lesion
first
describ
human
japanes
extract
underli
immunolog
basi
appear
cellmedi
immun
attack
melanot
tissu
nakamura
et
al
noros
yano
okada
et
al
rao
possibl
reaction
sugita
et
al
vkhlike
syndrom
describ
akita
dog
reusch
et
al
b
teifk
et
al
huski
malamut
samoy
chow
although
lesion
canin
diseas
bear
superfici
resembl
vkh
peopl
remain
proven
syndrom
dog
eye
much
less
like
involv
dog
skin
opposit
true
man
cn
sign
also
seen
dog
vkhlike
diseas
may
due
absenc
melanocyt
mening
dog
compar
peopl
confus
issu
mani
breed
may
skin
diseas
superfici
resembl
vkh
closer
examin
test
lesion
actual
caus
pemphigu
foliac
human
vkh
strongli
link
certain
hlatyp
exact
predispos
hla
type
differ
somewhat
accord
race
studi
arellanesgarcia
et
al
goldberg
et
al
islam
et
al
shindo
et
al
weisz
et
al
strong
breed
predisposit
dog
parallel
strong
ethnic
hla
type
predilect
peopl
type
iv
immun
diseas
nervou
system
granulomat
meningoenceph
gme
granulomat
meningoenceph
gme
progress
neurolog
disord
dog
braund
glastonburi
frauenfeld
murtaugh
et
al
sarfati
et
al
character
heterogen
inflammatori
infiltr
mhc
class
ii
posit
macrophag
posit
lymphocyt
kipar
et
al
dog
gme
tend
neurolog
sign
refer
head
lethargi
nuchal
rigid
anorexia
progress
caudal
fossal
abnorm
dementia
tetraparesi
profound
alter
conscious
sarfati
et
al
diagnosi
base
clinic
sign
markedli
elev
csf
protein
level
white
cell
count
csf
cell
consist
predominantli
lymphocyt
admixtur
neutrophil
bailey
higgin
dog
disord
respond
well
combin
therapi
glucocorticoid
leflunomid
natur
lesion
respons
immunosuppress
drug
therapi
suggest
disord
due
type
iv
autoimmun
reaction
old
dog
enceph
old
dog
enceph
delayedonset
canin
distemp
viru
cdv
enceph
result
cellular
immun
direct
viru
persist
brain
long
initi
immun
stage
infect
cdv
wildor
vaccinetyp
evan
et
al
probabl
mutat
manner
shapsak
et
al
tobler
imagawa
condit
analog
subacut
scleros
panenceph
spe
human
disord
associ
persist
genet
defect
measl
viru
brain
surpris
cdv
human
measl
viru
close
relat
member
genu
morbillaviru
lesion
old
dog
enceph
glial
prolif
diffus
spare
cerebellum
lesion
classic
cdv
encephalomyel
tend
focal
necrot
concentr
cerebellum
brain
stem
spine
vandeveld
et
al
old
dog
enceph
slowli
progress
enceph
occur
adult
vaccin
dog
differenti
type
chronic
encephalitid
gme
sign
usual
signific
although
mild
enceph
predomin
sign
loss
smell
report
beagl
simpson
myer
dog
delayedonset
cdv
enceph
unlik
anim
acut
demyelin
cdv
encephalomyel
high
level
cdv
antibodi
cerebr
spinal
fluid
indic
activ
local
immun
respons
johnson
et
al
antibodi
shown
direct
sole
protein
cdv
case
pattern
observ
homolog
measl
virusinduc
spe
human
remain
dog
demonstr
antibodi
nucleocapsid
phosoprotein
antigen
well
rima
et
al
six
type
chronic
hepat
describ
dog
chronic
activ
hepat
chronic
persist
hepat
chronic
cholestat
hepat
fibros
hepat
cirrhosi
chronic
cholangiohepat
miscellan
secondari
hepat
fuentealba
et
al
onethird
case
chronic
activ
type
chronic
activ
hepat
occur
commonli
doberman
pinscher
character
inflamm
scar
tissu
format
around
branch
small
hepat
vein
apoptosi
hepatocyt
zone
thornburg
inflammatori
reaction
consist
predominantli
macrophag
lymphocyt
plasma
cell
indic
type
iv
immun
reaction
exact
etiolog
condit
unknown
strong
breed
predisposit
tend
support
autoimmun
howev
autoimmun
suspect
caus
virtual
chronic
activ
hepat
peopl
hepat
b
c
g
viru
infect
number
therapeut
drug
demonstr
causal
agent
desmet
diseas
doberman
common
femal
usual
age
onset
sign
year
howev
biopsi
studi
indic
actual
lesion
may
present
five
year
condit
becom
clinic
speeti
et
al
clinic
sign
includ
weight
loss
atrophi
irregular
liver
parenchyma
ultrasonographi
elev
liver
enzym
sometim
jaundic
corticosteroid
therapi
may
benefici
affect
dog
dillmacki
paraproteinemia
character
pronounc
elev
normal
abnorm
immunoglobulin
blood
polyclon
gammopathi
broad
base
elev
immunoglobulin
class
idiopath
associ
infecti
immunolog
diseas
consequ
age
tendenc
immunoglobulin
level
rise
age
old
anim
human
gener
higher
immunoglobulin
level
especi
igg
younger
anim
elev
immunoglobulin
age
often
associ
increas
incid
autoantibodi
decreas
level
normal
cellular
immun
monoclon
gammopathi
character
elev
specif
immunoglobulin
class
usual
deriv
singl
clone
bcell
patholog
immunoglobulin
usual
direct
identifi
antigen
rare
case
howev
antibodi
specif
identifi
usual
patholog
effect
monoclon
antibodi
monoclon
immunoglobulin
also
call
mprotein
monoclon
gammopathi
either
benign
malign
latter
common
dog
line
polyclon
monoclon
gammopathi
blur
certain
chronic
infecti
diseas
fourteen
dog
chronic
ehrlichia
cani
infect
found
gammopathi
serum
protein
electrophoresi
demonstr
pattern
distinct
narrow
base
monoclon
spike
broad
base
monoclon
spike
monoclon
spike
superimpos
polyclon
spike
breitschwerdt
et
al
monoclon
gammopathi
caus
hyperviscos
acut
blind
also
seen
dog
ehrlichiosi
harru
et
al
german
shepherd
dog
ehrlichiosi
monoclon
gammopathi
treat
antibiot
plasmapheresi
matu
et
al
monoclon
gammopathi
also
observ
dog
plasmacyt
gasteroenter
gammopathi
resolv
dietari
immunosuppress
treatment
diehl
et
al
multipl
myeloma
malign
deriv
singl
plasma
cell
clonal
expand
myeloma
produc
immunoglobulin
part
immunoglobulin
macewen
et
al
mark
et
al
whole
immunoglobulin
class
couto
et
al
finni
wilk
kirschner
et
al
orr
et
al
part
immunoglobulin
light
heavi
chain
hoenig
myeloma
occur
almost
exclus
age
anim
myeloma
dog
recogn
frequent
doberman
pinscher
hoenig
breed
myeloma
dog
iga
igg
igm
small
percentag
lymphoblastoid
tumor
bcell
origin
usual
cll
secret
mprotein
breuer
et
al
common
mprotein
associ
bcell
lymphosarcoma
igm
follow
igg
iga
usual
secret
lymphoblastoid
cell
tumor
featur
lymphosarcoma
secret
mprotein
similar
describ
multipl
myeloma
clinic
sign
refer
space
occupi
lesion
usual
flat
bone
skull
vertebra
rib
pelvi
caus
pain
limp
diarrhea
neurolog
sign
etc
gibson
et
al
maeda
et
al
raskin
krehbiel
tuch
tuch
soft
tissu
liver
spleen
intestin
bone
marrow
kato
et
al
peterson
meining
hyperviscos
syndrom
usual
associ
iga
igm
myeloma
center
smith
kirschner
et
al
cryoglobulinemia
abnorm
protein
precipit
cool
paraneoplast
syndrom
hendrix
et
al
villier
dobson
amyloidosi
associ
catabol
immunoglobulin
geisel
et
al
platz
et
al
immunosuppress
normal
immunoglobulin
greatli
depress
anim
monoclon
gammopathi
myeloma
dog
equal
distribut
skeleton
usual
flat
bone
soft
tissu
organ
intestin
tract
spleen
intern
organ
plasma
cell
leukemia
rare
couto
et
al
bone
lesion
often
lyric
natur
area
vertebr
bodi
clinic
sign
paresi
may
result
tumor
involv
intern
organ
like
associ
vagu
sign
diseas
weight
loss
occur
mani
week
month
hyperviscos
syndrom
specif
complic
certain
monoclon
gammopathi
igm
iga
mprotein
present
high
enough
concentr
greatli
increas
viscos
serum
hyperviscos
lead
turn
increas
load
heart
hypertens
vascular
thrombosi
due
blood
sludg
smaller
vessel
anim
hyperviscos
syndrom
commonli
present
sign
heart
failur
collaps
retin
hemorrhag
acut
neurolog
sign
mprotein
usual
igm
class
behav
cryoglobulin
precipit
smaller
blood
vessel
serum
cool
cryoglobulinemia
usual
associ
gangren
extrem
ear
tip
digit
eyelid
tip
tail
etc
exposur
cold
weather
may
exacerb
precipit
clinic
sign
pathogen
function
mprotein
may
relat
specif
antibodi
bind
host
antigen
mprotein
behav
cold
agglutinin
anim
present
sign
refer
hemolyt
anemia
thrombosi
human
bizarr
neurolog
syndrom
found
mprotein
specif
nerv
tissu
antigen
similar
situat
may
occur
german
shepherd
dog
multipl
myeloma
associ
polyneuropathi
neuropathi
disappear
dog
given
chemotherapi
tumor
gammopathi
resolv
villier
dobson
amyloidosi
common
sometim
fatal
sequela
idiopath
monoclon
gammopathi
immunoglobulinsecret
malign
man
relationship
amyloidosi
monoclon
gammopathi
obviou
anim
probabl
anim
much
lower
incid
idiopath
monoclon
gammopathi
man
therefor
apt
present
common
sign
tumor
immunosuppress
hypogammaglobulinemia
frequent
associ
monoclon
gammopathi
peopl
peopl
gammopathi
abnorm
low
level
normal
immunoglobulin
suffer
chronic
skin
respiratori
intestin
tract
infect
immunosuppress
howev
usual
associ
monoclon
gammopathi
anim
probabl
due
low
incid
idiopath
monoclon
gammopathi
anim
compar
man
total
protein
level
usual
elev
anim
gammopathi
may
first
tipoff
condit
mani
condit
fals
rais
total
protein
level
measur
refractomet
eg
hyperbilirubinemia
hyperlipidemia
hyperfibrinogenemia
hemolysi
dehydr
total
protein
albumin
level
measur
autom
chemistri
panel
probabl
better
indic
globin
increas
tp
albumin
globulin
serum
electrophoresi
give
rel
measur
concentr
major
protein
serum
monoclon
protein
may
show
specif
mprotein
spike
electrophoresi
profil
serum
level
igg
iga
igm
measur
radialimmunodiffus
assay
polyclon
gammopathi
elev
ig
class
monoclon
gammopathi
elev
one
ig
class
depress
other
serum
also
test
hyperviscos
serum
allow
drip
pipett
tip
needl
time
requir
given
volum
normal
serum
pass
needl
pipett
compar
time
requir
abnorm
serum
test
also
run
compar
time
abnorm
normal
drop
serum
take
run
bottom
inclin
glass
plate
cryoglobulin
usual
pick
technician
autom
blood
chemistri
precipit
cool
serum
usual
plug
tip
sampl
aspir
serum
cool
centrifug
dens
precipit
sediment
bottom
tube
precipit
dissolv
warm
common
test
monoclon
gammopathi
human
protein
test
urin
protein
mainli
light
chain
immunoglobulin
excess
light
chain
secret
urin
occur
result
catabol
larg
amount
mprotein
origin
myeloma
produc
free
light
chain
rather
intact
immunoglobulin
urin
treat
nh
precipit
indic
presenc
protein
unfortun
protein
test
diagnost
dog
myeloma
dog
produc
free
light
chain
treatment
polyclon
gammopathi
never
direct
product
immunoglobulin
per
se
rather
incit
caus
multipl
myeloma
treat
prednisolon
alkyl
agent
alkeran
phenylalanin
mustard
prognosi
good
remiss
dog
longterm
prognosi
poor
due
relaps
specif
lymphoma
chemotherapi
protocol
use
treat
monoclon
antibodi
produc
prebcel
tumor
hyperviscos
problem
plasmapheresi
remov
plasma
indic
treatment
may
necessari
lower
level
monoclon
cold
agglutinin
follow
discuss
base
review
immun
system
dog
human
speci
felsburg
janeway
traver
immun
innat
adapt
natur
innat
immun
mechan
nonspecif
requir
previou
experi
invad
microb
immedi
avail
innat
immun
effect
microorgan
encount
daili
life
caus
percept
diseas
occas
contrast
adapt
immun
occur
microb
breach
innat
defens
microb
tend
highli
antigen
specif
requir
sever
day
reach
maximum
growth
adapt
immun
respons
character
gener
antigenspecif
cell
band
tlymphocyt
specif
target
pathogen
well
memori
cell
allow
rapid
respons
reinfect
innat
immun
appear
earli
evolut
sole
defens
mechan
lower
anim
variou
compon
innat
immun
system
serv
evolutionari
scaffold
subsequ
adapt
immun
respons
stepwis
evolut
recapitul
immun
respons
innat
immun
slow
infect
thu
allow
time
adapt
immun
take
hold
provid
trigger
scaffold
adapt
immun
reaction
develop
epitheli
mucos
barrier
first
line
defens
mucosa
thrown
microvilli
increas
surfac
area
retain
mucu
layer
air
case
respiratori
tract
digesta
case
intestin
tract
move
surfac
film
mucou
film
contain
phagocyt
number
nonspecif
antimicrobi
substanc
cornifi
layer
skin
seal
protect
live
cell
underneath
act
spong
normal
flora
nonspecif
protect
substanc
nonspecif
antimicrobi
substanc
includ
fatti
acid
skin
lysozym
saliva
sweat
tear
pepsin
gut
hydrochlor
acid
stomach
antibacteri
peptid
defensin
intestin
normal
skin
mucos
flora
also
compet
nutrient
attach
epithelium
produc
antimicrobi
substanc
altern
pathway
complement
activ
anoth
arm
innat
immun
respons
constantli
convert
activ
low
level
attract
cell
membran
activ
combin
anoth
serum
protein
call
bb
form
complex
addit
protein
call
mcp
daf
present
surfac
normal
cell
act
inactiv
complex
convertas
lead
convers
surfac
mani
microb
lack
enzym
henc
cell
bound
inactiv
act
opsonin
phagocyt
activ
complement
cascad
properdin
system
anoth
potent
nonspecif
defens
mechan
mani
microb
favor
bind
properdin
factor
p
factor
p
stabil
complex
thu
prevent
dissoci
allow
buildup
activ
classic
complement
pathway
macrophag
also
play
key
role
innat
immun
trigger
cell
mani
adapt
immun
respons
macrophag
matur
continu
circul
monocyt
leav
circul
migrat
tissu
throughout
bodi
macrophag
possess
number
surfac
receptor
microb
includ
mannos
receptor
scaveng
receptor
bacteri
lipopolysaccharid
bind
receptor
leukocyt
integrin
receptor
bind
surfac
protein
wide
rang
microbi
pathogen
thu
trigger
phagocytosi
secret
cytokin
tnf
cytokin
key
substanc
develop
adapt
immun
induc
local
inflamm
attract
inflammatori
cell
area
increas
product
adhes
molecul
vascular
endothelium
inflammatori
cell
includ
neutrophil
eosinophil
lymphocyt
monocyt
increas
vascular
permeabl
also
result
lead
influx
fluid
microphag
ie
neutrophil
abund
bloodstream
normal
found
outsid
blood
vessel
normal
circumst
innat
immun
respons
produc
mani
substanc
chemotact
neutrophil
bacteri
cell
wall
compon
bind
directli
membran
receptor
neutrophil
lipopolysaccharid
bind
protein
serum
bind
bacteri
lp
complex
bound
neutrophil
bacteria
phagocytos
neutrophil
kill
toxic
oxygen
metabolit
proteas
phospolipas
defensin
acut
phase
reactant
also
function
innat
immun
system
certain
protein
produc
respons
releas
cytokin
tnf
creactiv
protein
consist
five
ident
subunit
bind
phosphoryl
chlolin
cell
wall
bacteria
fungi
creactiv
protein
bind
microbi
cell
wall
induc
opson
activ
complement
cascad
mannos
bind
protein
also
react
mannos
residu
surfac
mani
microb
induc
phagocytosi
complement
activ
interferon
small
protein
produc
viru
infect
cell
interferon
produc
mani
type
viru
infect
cell
act
distant
cell
render
resist
viral
replic
interferon
induc
innat
phase
immun
interferon
g
appear
adapt
stage
immun
respons
interferon
also
activ
natur
killer
nk
cell
upregul
mhc
class
receptor
express
latter
activ
protect
normal
cell
nonspecif
destruct
nk
cell
natur
killer
cell
popul
tlymphocyt
lack
surfac
marker
nk
cell
evolv
much
earlier
phylogeni
tand
bcell
respons
adapt
immun
nk
cell
becom
potent
killer
receiv
specif
activ
signal
nk
cell
activ
enhanc
interferon
therefor
invas
host
cell
microbi
pathogen
activ
nk
cell
activ
nk
cell
bind
infect
cell
sever
mechan
infect
cell
elabor
increas
level
sulfat
proteoglycan
surfac
nk
cell
receptor
bind
substanc
nk
cell
bind
lead
elabor
cytotoxin
act
short
rang
activ
nk
cell
killer
cell
inhibit
howev
nk
cell
identifi
selfmhci
protein
henc
import
constant
mhci
upregul
normal
cell
viru
infect
cell
elabor
fewer
receptor
either
viral
interfer
protein
synthesi
viru
block
export
cell
surfac
cell
resist
interferon
induc
upregul
host
cell
display
mhci
kill
activ
nk
cell
also
evid
viru
infect
cell
may
introduc
new
peptid
mhc
receptor
thu
prevent
normal
selfrecognit
nk
cell
tcell
bear
g
cell
surfac
protein
found
specif
epitheli
surfac
skin
mucosa
recircul
surfac
receptor
homogen
one
epithelium
homogen
receptor
thought
g
tcell
recogn
specif
microb
rather
respond
nonspecif
chang
induc
particular
epithelium
result
insult
usual
microbi
g
tcell
recogn
epitheli
cell
affect
stress
heat
shock
protein
well
cell
aberr
express
selfrecognit
ie
mhc
marker
intraepitheli
g
tcell
possess
killer
activ
follow
receptor
bind
cell
innat
immun
also
involv
certain
subpopul
bcell
product
specif
antibodi
convent
bcell
import
adapt
immun
howev
separ
lineag
bcell
ie
limit
v
gene
divers
selfrenew
without
previou
exposur
antigen
tcell
independ
predomin
certain
area
bodi
periton
caviti
undergo
immunoglobulin
class
switch
predomin
immunoglobulin
product
igm
bcell
exhibit
immunolog
memori
antibodi
product
peak
h
much
faster
regular
bcell
undergo
adapt
immun
respons
bcell
make
antibodi
mainli
polysaccharid
antigen
present
mani
bacteri
cell
wall
thought
bcell
evolutionari
precursor
convent
bcell
g
tcell
may
precursor
tcell
natur
antibodi
produc
bcell
probabl
play
import
role
natur
defens
bacteri
infect
especi
within
periton
caviti
tcell
bear
surfac
marker
central
adapt
immun
preced
evolut
g
tcell
first
step
adapt
immun
antigen
recognit
tcell
activ
tcell
activ
occur
antigen
free
cellassoci
encount
drain
lymphoid
organ
antigen
form
particul
substanc
whole
microb
taken
macrophag
antigen
present
cell
cell
present
specif
antigen
signal
surfac
either
context
mhci
cellassoci
microb
mhcii
ingest
particul
antigen
activ
innat
immun
system
lead
monokin
releas
increas
traffick
lymphocyt
involv
lymphoid
organ
increas
traffick
naiv
tcell
increas
likelihood
cell
bear
appropri
receptor
brought
contact
correspond
antigen
tcell
differenti
central
direct
adapt
immun
respons
naiv
tcell
contact
specif
antigen
process
differenti
trigger
differenti
follow
two
gener
path
cell
becom
inflammatori
effector
tcell
ie
thelper
cell
helper
tcell
ie
thelper
two
cell
cours
cell
take
immun
respons
depend
cytokin
milieu
gener
innat
phase
immun
gener
speak
gener
cellmedi
immun
induc
antibodi
product
tcell
activ
manner
destin
becom
specif
cell
killer
ie
cytotox
tcell
teffector
cell
fulli
activ
day
infect
guid
specif
site
infect
upregul
surfac
marker
integrin
surfac
correspond
upregul
receptor
cell
adhes
molecul
selectin
surfac
endotheli
cell
target
area
inflammatori
tcell
activ
macrophag
site
infect
greatli
enhanc
abil
kill
intracellular
microb
cytotox
cell
act
manner
similar
nk
cell
kill
infect
cell
activ
teffector
cell
attach
infect
target
cell
doubl
key
mechan
identifi
specif
antigen
array
within
mhc
recogn
selfmark
also
mhc
see
discuss
section
innat
immun
proper
recognit
signal
receiv
teffector
cell
elabor
cytotoxin
kill
abnorm
cell
naiv
bcell
possess
appropri
surfac
receptor
activ
contact
arm
thelper
cell
specif
one
peptid
deriv
antigen
specif
stimul
bcell
undergo
rapid
clonal
expans
differenti
go
matur
rest
bcell
plasmablast
final
plasma
cell
initi
antibodi
product
usual
igm
type
occur
lymphoblast
tcell
area
lymphoid
organ
plasmablast
migrat
bone
marrow
medullari
cord
becom
sessil
plasma
cell
plasma
cell
highli
effici
antibodi
product
undergo
class
switch
igm
igg
iga
sustain
low
level
antibodi
product
prolong
period
time
igm
pentamer
form
igg
first
immunoglobulin
class
evolv
lower
fish
ontogeni
recapitul
phylogeni
igm
also
first
antibodi
system
develop
fetu
first
class
antibodi
appear
evolut
individu
immun
respons
instanc
new
born
puppi
produc
igm
upon
antigen
stimuli
late
gestat
birth
igg
iga
respons
take
sever
week
longer
manifest
week
age
older
puppi
infect
microb
first
antibodi
appear
igm
class
follow
later
igg
iga
igm
primit
import
immunoglobulin
class
igm
antibodi
strong
complement
binder
strongli
lyric
circul
plasma
secret
unto
mucou
membran
therefor
igm
share
mani
function
found
collect
ig
subclass
igg
make
circul
antibodi
unlik
igm
gain
access
interstiti
fluid
predomin
antibodi
made
lymph
node
spleen
major
import
system
microbi
infect
iga
dimer
evolv
igm
igg
produc
greatest
amount
diffus
lymphoid
aggreg
princip
secretori
antibodi
iga
system
littl
immunolog
memori
depend
continu
antigen
exposur
mainten
iga
import
control
local
infect
mucou
membran
ige
monom
recent
evolv
ig
like
iga
ige
secret
mainli
plasma
cell
present
diffus
lymphoid
aggreg
underli
skin
mucou
membran
ige
noncompl
bind
intim
associ
circul
basophil
tissu
mast
cell
ige
bind
great
avid
cell
membran
receptor
present
cell
ige
associ
mastcel
respons
intim
associ
parasit
immun
although
antibodi
bind
provid
specif
ultim
effect
bind
usual
determin
complement
complement
system
compris
larg
number
distinct
plasma
protein
initi
complement
compon
appropri
trigger
surfac
pathogen
either
antibodi
lectin
mannos
alternativepathway
cascad
reaction
occur
preced
protein
act
enzym
activ
subsequ
protein
earlier
compon
cascad
act
recruit
phagocyt
site
enhanc
opson
termin
complement
compon
lead
microbi
lysi
classic
pathway
molecul
bind
antibodi
molecul
trigger
buildup
convertas
pathogen
surfac
activ
complement
cascad
also
activ
lectin
pathway
mannosebind
protein
bind
mannan
pathogen
surfac
lead
buildup
convertas
mbp
masp
third
altern
pathway
complement
activ
involv
buildup
protein
b
pathogen
surfac
lead
convertas
one
outcom
adapt
immun
establish
immunolog
memori
memori
abil
immun
respons
respond
rapidli
effici
pathogen
encount
previous
immunolog
memori
reli
clonal
expans
clonal
differenti
specif
memori
lymphocyt
primari
immun
respons
memori
tcell
longliv
retain
antigen
either
particul
organism
may
import
mainten
memori
characterist
featur
immunodefici
infect
caus
microb
normal
pathogen
unusu
sever
persist
infect
normal
mild
selflimit
inordin
number
differ
infect
individu
recurr
infect
occur
subclin
form
earlier
life
infect
unexplain
difficult
treat
immunodefici
state
involv
either
innat
adapt
immun
respons
congenit
acquir
origin
congenit
immunodefici
congenit
defect
innat
immun
congenit
caus
innat
immunodefici
vari
common
human
increasingli
recogn
dog
although
littl
clinic
research
dog
regard
defici
classic
aspect
innat
immun
sever
area
defect
obviou
normal
anatomi
essenti
integr
individu
peopl
think
immun
studi
anatomi
howev
anatom
defect
probabl
common
caus
innat
immunodefici
relat
ill
dog
tissu
cover
extern
intern
bodi
surfac
import
compon
innat
immun
skin
outer
cornifi
layer
resist
microbi
growth
invas
glandular
secret
onto
skin
mucou
membran
also
contain
nonspecif
antimicrobi
substanc
sharpei
dog
abnorm
skin
predispos
constant
skin
infect
cilia
mucou
membran
especi
respiratori
genitourinari
tract
act
broom
trap
sweep
foreign
materi
ciliari
layer
also
act
substrat
trap
hold
mucu
secret
congenit
defect
cilia
render
immobil
occur
human
anim
dog
immobil
cilia
syndrom
primari
ciliari
dyskinesia
suffer
greatli
recurr
difficult
treat
infect
upper
lower
airway
edward
et
al
small
brachycephal
breed
dog
suffer
much
periodont
diseas
larger
sport
breed
small
breed
often
malposit
jaw
teeth
alter
pressur
normal
place
periodonti
ligament
mani
small
breed
chew
hard
object
decreas
exercis
periodonti
tissu
prevent
tarter
remov
net
effect
abnorm
forc
gradual
weaken
periodonti
ligament
tooth
mobil
periodonti
pocket
format
bacteri
colon
periodont
result
local
bone
resorpt
tooth
instabl
wide
rang
anatom
anomali
tissu
skin
mucou
membran
associ
immunodefici
instanc
sphincter
urogenit
gastrointestin
respiratori
tract
act
door
prevent
influx
microb
anim
congenit
anomali
urethr
sphincter
ectop
uret
leak
urin
continu
outsid
bacteria
grow
urin
stream
infect
bladder
anim
abnorm
uret
obstruct
normal
urin
flow
kidney
often
develop
hydrouret
hydronephrosi
anim
prone
sever
recurr
bacteri
pyelonephr
anim
congenit
anomali
larynx
may
aspir
food
lung
develop
pneumonia
individu
cleft
hard
soft
palat
frequent
develop
chronic
nasal
infect
due
foreign
materi
drawn
nasal
caviti
certain
breed
dog
flatten
face
protrud
eye
may
problem
tear
drainag
caus
excess
wet
around
eye
bacteri
overgrowth
similar
situat
occur
anim
congenit
blockag
lacrim
duct
dog
much
prone
extern
ear
infect
speci
length
angul
extern
ear
canal
dog
hair
grow
ear
canal
even
prone
infect
dog
substanc
secret
onto
skin
mucou
membran
variou
gland
import
nonspecif
microbi
function
dog
secret
littl
substanc
onto
skin
much
prone
chronic
recurr
skin
infect
paradox
much
secret
effect
therefor
anim
seborrhea
sicca
seborrhea
oleosa
suffer
chronic
skin
infect
congenit
defect
adapt
immun
congenit
anomali
virtual
aspect
adapt
immun
occur
peopl
anim
literatur
anomali
gener
natur
occur
diseas
human
inbr
strain
laboratori
mice
congenit
defect
phagocytosi
rang
mild
highli
lethal
depend
natur
sever
sever
defect
usual
lead
earli
death
less
sever
phagocyt
defect
often
seen
clinic
defect
leukocyt
adhes
molecul
neutrophil
occur
xlink
recess
trait
irish
setter
trowaldwigh
et
al
affect
anim
suffer
recurr
fever
polyarthr
skin
lesion
stunt
growth
almost
birth
seldom
live
past
one
year
age
extrem
high
level
matur
hyperseg
neutrophil
blood
neutrophil
summon
larg
number
bone
marrow
find
way
site
inflamm
poorli
character
neutrophil
phagocyt
abnorm
report
weimeran
associ
recurr
infect
hansen
et
al
cyclic
neutropenia
grey
grey
colli
dog
rare
mongrel
similar
coat
color
profound
cyclic
fluctuat
usual
day
period
number
neutrophil
yang
disord
due
autosom
recess
gene
ident
human
cyclic
neutropenia
yang
period
bone
marrow
inact
neutropenia
follow
period
flamboy
bone
marrow
activ
character
monocytosi
thrombocytosi
reticulocytosi
neutrophilia
pratt
et
al
affect
dog
prone
local
system
bacteri
infect
often
cyclic
natur
patholog
effect
cumul
affect
puppi
rare
surviv
six
month
age
yang
disord
due
herit
recess
regulatori
defect
hematopoiet
stem
cell
dale
et
al
abnorm
respons
granulocyt
coloni
stimul
factor
gcsf
implic
pathophysiolog
syndrom
particular
defect
gcsf
signal
transduct
pathway
distal
gcsf
receptor
express
bind
avalo
et
al
neutropenia
greatli
improv
gcsf
treatment
although
cycl
still
observ
lothrop
et
al
mishu
et
al
better
result
may
obtain
gcsf
given
combin
stem
cell
factor
dale
et
al
complement
defici
involv
number
individu
compon
classic
altern
complement
protein
describ
man
variou
anim
speci
abnorm
involv
either
total
absenc
complement
factor
product
factor
structur
function
abnorm
dog
complement
defici
often
live
adulthood
beyond
tend
suffer
atyp
recurr
persist
infect
skin
respiratori
tract
ameratunga
et
al
blum
et
al
human
complement
defici
also
higher
incid
immunolog
diseas
sle
rheumatoidlik
arthriti
sleasman
herit
defici
humor
immun
surprisingli
common
usual
involv
defici
specif
immunoglobulin
class
common
herit
defici
type
man
anim
involv
iga
peopl
lack
iga
absolut
defici
iga
common
chines
shar
pei
partial
defici
common
german
shepherd
dog
day
penhal
disord
also
observ
breed
beagl
iga
defici
manifest
increas
incid
skin
respiratori
infect
felsburg
et
al
individu
iga
defici
often
problem
allergi
probabl
ige
system
call
upon
compens
lack
igamedi
immun
sever
bloodlin
coloni
english
cocker
spaniel
report
rel
iga
defici
high
incid
ana
coomb
antibodi
sle
hypothyroid
idiopath
cardiomyopathi
day
b
c
attempt
link
aspergillosi
german
shepherd
dog
variabl
iga
defici
neg
day
penhal
german
shepherd
dog
appear
select
inabl
mount
normal
humor
immun
respons
major
dog
system
aspergillosi
caus
terreu
develop
demonstr
antibodi
respons
organ
agar
gel
diffus
counter
immunoelectrophoresi
elisa
indirect
immunofluoresc
day
penhal
howev
anim
significantli
increas
polyclon
igg
product
sever
combin
immunodefici
commonli
known
scid
occur
man
anim
usual
associ
herit
defect
metabol
pathway
critic
tcell
develop
classic
form
scid
boy
glass
bubbl
associ
adenin
deaminas
defici
similar
diseas
differ
genet
basi
occur
basset
hound
affect
bassett
hound
often
develop
canin
distemp
week
age
matern
immun
wane
sourc
distemp
viru
live
viru
vaccin
anim
develop
distemp
usual
fail
thrive
die
month
age
scid
associ
xlink
defect
receptor
function
describ
famili
cardigan
welsch
corgi
deschen
et
al
jezyk
et
al
pullen
et
al
defect
caus
singl
nucleotid
insert
g
chain
canin
receptor
somberg
et
al
defect
observ
subset
peopl
scid
clinic
featur
includ
failur
thrive
hypogammaglobulinemia
absent
tcell
mitogen
respons
thymic
dysplasia
lymphoid
hypoplasia
snyder
et
al
somberg
et
al
dog
rais
convent
environ
usual
die
environment
vaccineviru
associ
infect
five
month
age
dog
defect
maintain
indefinit
gnotobiot
environ
although
incid
leukemia
may
increas
select
immunodefici
unknown
type
well
describ
dog
virtual
alway
purebr
german
shepherd
dog
known
much
suscept
ehrlichia
cani
infect
mongrel
beagl
nyindo
et
al
nasal
aspergilla
fumigatu
system
aspergillosi
terreu
berri
leisewitz
day
penhal
b
day
et
al
day
et
al
kabay
et
al
mortellaro
et
al
gener
pyoderma
rosser
rottweil
particularli
suscept
parvoviru
infect
nasal
system
fungal
infect
oral
papillomaviru
infect
bredal
et
al
certain
dachshund
develop
sever
pneumocysti
carinii
infect
lung
lobetti
et
al
disord
describ
human
aid
patient
certain
subset
young
medleau
willems
occasion
age
duclo
et
al
dog
appear
suscept
system
demodect
mang
great
dane
doberman
pincher
suscept
cryptococc
infect
breed
malik
et
al
labrador
golden
retriev
time
suscept
type
glomerulonephr
put
associ
borrelia
burgdorferi
infect
dambach
et
al
neospora
caninum
infect
neonat
adult
form
almost
alway
observ
purebr
dog
barber
tree
cuddon
et
al
flagstad
et
al
jacobson
jardin
poli
et
al
pumarola
et
al
dog
select
immunodefici
normal
immun
respons
infecti
agent
normal
complement
ig
level
even
respond
favor
treat
properli
problem
infect
day
et
al
uncharacter
immunodefici
report
sever
breed
immunodefici
syndrom
describ
irish
setter
cauvin
connolli
intrigu
syndrom
manifest
acut
fever
gastrointestin
sign
malais
observ
weimeran
puppi
couto
et
al
initi
sign
vari
sever
often
follow
mild
sever
hypertroph
osteodystrophi
hod
woodard
anim
recurr
diseas
sign
involv
alimentari
tract
joint
skin
peripher
lymph
node
central
nervou
system
conjunctiva
persist
adolesc
condit
reportedli
associ
variabl
decreas
one
immunoglobulin
isotop
couto
et
al
day
et
al
possibl
neutrophil
function
abnorm
couto
et
al
hansen
et
al
although
breeder
feel
condit
trigger
vaccin
dodd
puppi
develop
condit
even
vaccin
condit
appear
fall
categori
common
variabl
immunodefici
cvid
human
cvid
heterogen
syndrom
spickett
et
al
character
humor
immunodefici
involv
one
immunoglobulin
isotyp
recurr
bacteri
infect
varieti
immunolog
abnorm
eibl
wolf
eisenstein
sneller
affect
human
show
variou
defect
tcell
regul
bcell
bcell
activ
cytokin
respons
howev
notabl
differ
weimaran
syndrom
cvid
peopl
diseas
occur
sole
puppi
wherea
cvid
seen
infant
children
adult
cvid
rare
selflimit
wherea
mani
affect
dog
appear
outgrow
condit
affect
dog
respond
dramat
steroid
therapi
human
treat
g
globulin
compens
antibodi
defici
inappropri
treat
mani
affect
weimaran
puppi
die
euthanit
glucocorticoid
treatment
highli
effect
break
febril
respons
resolv
system
sign
hasten
resolut
hod
unfortun
mani
veterinarian
use
treatment
mistakenli
view
condit
pure
immunodefici
suspect
primari
immunodefici
syndrom
seen
three
relat
irish
wolfhound
leisewitz
et
al
dog
present
less
one
year
age
histori
chronic
nasal
discharg
persist
lower
respiratori
tract
diseas
sign
improv
antibiot
treatment
recur
treatment
stop
cellmedi
immunodefici
suspect
base
cursori
test
diagnosi
compat
type
clinic
sign
iga
complement
defici
cilliari
dyskinesi
would
like
caus
primari
immunodefici
syndrom
may
also
occur
chines
sharpei
dog
riva
et
al
present
sign
recurr
infect
malign
abnorm
low
level
serum
igm
iga
present
affect
dog
low
igg
lesser
proport
acquir
immunodefici
innat
immun
diseas
compromis
integr
epidermi
overli
cornifi
layer
complic
secondari
infect
resid
bacteria
especi
aureu
burn
atop
dermat
flea
bite
dermat
bullou
diseas
exampl
primari
skin
diseas
often
complic
secondari
infect
normal
flora
skin
oropharynx
lower
gi
tract
prevent
establish
abnorm
flora
normal
flora
compromis
patholog
flora
take
select
advantag
situat
problem
particularli
seriou
antibiot
use
presenc
antibiot
resist
microorgan
mani
surgic
procedur
requir
use
endotrach
tube
forc
respir
inhal
anesthet
gase
endotrach
tube
effect
bypass
innat
immun
provid
upper
airway
carri
oral
bacteria
mainstem
bronchi
forc
respir
anesthesia
drive
secret
upper
air
passag
lower
airway
seriou
problem
alreadi
preexist
lung
diseas
indwel
urinari
cathet
major
sourc
infect
urinari
tract
iv
cathet
major
sourc
infect
blood
urethrostomi
frequent
lead
cystiti
tracheostomi
tracheobronch
oronas
fistula
rhiniti
acquir
anomali
phagocytosi
usual
due
condit
markedli
decreas
number
avail
phagocyt
contract
congenit
phagocyt
anomali
usual
associ
decreas
function
phagocyt
either
case
net
effect
diminish
phagocyt
capac
usual
manifest
increas
incid
infect
caus
bacteria
anticanc
drug
therapi
often
lead
profound
cytopenia
induct
stage
treatment
put
grave
risk
infect
autoimmun
drug
induc
neutropenia
immun
origin
often
manifest
fever
sepsi
nineti
percent
dog
necropsi
acut
parvoviru
infect
recover
e
coli
lung
liver
secondari
infect
candida
albican
rodraiguez
et
al
clostridium
perfringen
turk
et
al
edwardsiella
tarda
van
assch
also
describ
secondari
infect
occur
profound
neutropenia
effac
intestin
barrier
antineoplast
drug
therapi
aplast
anemia
myeloid
tumor
may
associ
sever
neutropenia
secondari
infect
dog
diabet
mellitu
human
dog
associ
defect
neutrophil
function
diabet
dog
greatli
increas
incid
bacteri
cystiti
kirsch
hepat
abscess
also
describ
two
dog
diabet
mellitu
grooter
et
al
select
suppress
cellular
immun
acquir
diseas
uncommon
cellular
humor
immun
usual
effect
togeth
drug
like
cyclosporin
much
affect
cellular
immun
humor
immun
corticosteroid
inactiv
infect
kept
contain
mainli
cellular
immun
eg
latent
ringworm
demodect
mang
infect
splenectomi
dog
lead
reactiv
latent
haemobartonella
cani
infect
chronic
corticosteroid
treatment
frequent
lead
bacteri
cystiti
especi
femal
dog
canin
distemp
viru
infect
induc
sever
combin
tand
bcell
immunodefici
dog
distemp
often
intract
secondari
bacteri
infect
lung
intestin
tract
unusu
type
infect
neosporosi
inde
chronic
distemp
older
dog
shelter
kennel
may
manifest
immunodefici
rather
neurolog
problem
acquir
defici
humor
immun
uncommon
immunoglobulin
secret
myeloma
lymphosarcoma
frequent
associ
profound
depress
immunoglobulin
class
acquir
hypogammaglobulinemia
describ
occasion
dog
rel
common
human
affect
individu
delay
product
immunoglobulin
usual
normal
matern
immun
declin
suffer
system
bacteri
infect
defect
usual
correct
time
failur
passiv
system
immun
seriou
problem
foal
calv
less
common
puppi
nevertheless
puppi
fail
nurs
rear
milk
replac
lack
passiv
system
local
immun
puppi
suscept
overwhelm
intestin
blood
infect
bacteri
origin
tissu
organ
transplant
routin
human
medicin
appli
limit
basi
veterinari
medicin
greatest
hurdl
prevent
widespread
use
organ
transplant
man
anim
problem
tissu
incompat
graft
immun
bodi
complex
immun
mechan
recogn
destroy
tissu
foreign
anim
develop
mechan
identifi
destroy
live
tissu
speci
xenogen
tissu
understand
reason
complex
microorgan
parasit
bacteria
fungi
protozoa
virus
essenti
xenograft
tri
establish
bodi
fail
recogn
foreign
could
caus
death
anim
xenogen
tissu
graft
mous
cat
tissu
implant
dog
treat
invad
microorgan
bodi
develop
mechan
recogn
destroy
tissu
member
speci
allogen
tissu
easi
understand
individu
one
speci
normal
invad
bodi
member
speci
alloimmun
seem
unnecessari
theoriz
selfrecognit
import
prevent
autoimmun
emerg
mutant
cell
could
harm
bodi
eg
cancer
graft
reject
may
also
necessari
side
effect
mhc
divers
divers
mhc
essenti
surviv
speci
expos
new
infect
except
pregnanc
allogen
tissu
attack
host
allogen
immun
continu
oper
complic
whole
approach
medicin
allogen
immun
organ
could
freeli
easili
exchang
one
individu
anoth
allogen
immun
surgeon
must
spend
much
time
patch
old
part
bypass
defect
part
whenev
possibl
replac
faulti
part
new
one
made
plastic
metal
substanc
evok
host
respons
trigger
tissu
incompat
rest
structur
protein
found
surfac
cell
protein
allow
immun
system
discern
whether
tissu
autolog
syngen
speci
differ
individu
homolog
allogen
organ
differ
speci
altogeth
heterolog
xenogen
greater
differ
antigen
tissu
host
immunogen
tissu
rapidli
recogn
destroy
although
live
xenograft
rare
given
xenogen
tissu
pericardium
catgut
wide
use
surgeri
graft
howev
serv
scaffold
repopul
host
tissu
immunogen
greatli
diminish
chemic
treatment
allograft
reaction
much
stronger
dog
virtual
speci
includ
human
appear
due
greater
degre
genet
divers
among
dog
genet
divers
within
breed
surprisingli
small
rather
violenc
allograft
reject
dog
seem
intrins
properti
allograft
immun
speci
great
deal
known
major
histocompat
antigen
dog
use
dog
human
transplant
research
antigen
dog
cell
defin
allogen
differ
found
mani
cell
type
graft
alloantigen
rich
passeng
host
lymphocyt
graft
endothelium
leukocyt
particularli
rich
histocompat
antigen
easi
collect
blood
tissu
choic
earli
research
earli
research
use
alloantibodi
mixedlymphocyt
reaction
defin
histocompat
differ
individu
antigen
defin
histocompat
differ
code
gene
within
major
histocompat
complex
mhc
call
dog
leukocyt
dl
antigen
gene
mhc
found
singl
chromosom
first
group
dl
antigen
defin
call
henc
term
dla
antigen
current
design
gene
allel
mhc
dog
increasingli
deriv
actual
dna
sequenc
dla
gene
belong
either
mhc
class
mhc
class
ii
class
gene
initi
defin
serolog
class
ii
gene
base
mix
lymphocyt
reactiv
bull
et
al
vriesendorp
et
al
vriesendorp
et
al
vriesendorp
sever
sequencebas
studi
canin
mhc
type
gene
report
burnett
et
al
graumann
et
al
wagner
et
al
least
four
mhc
class
gene
wager
et
al
least
allel
class
loci
fewer
allel
within
dog
mhc
class
ii
region
clear
homologu
identifi
human
dra
drb
dqa
dqb
kennedi
et
al
b
polvi
et
al
sarmiento
et
al
sarmiento
et
al
sarmiento
et
al
wagner
et
al
wagner
et
al
b
two
gene
dq
region
one
gene
dr
region
use
dna
sequenc
data
differ
allel
identifi
gene
allel
loci
allel
gene
kennedi
et
al
b
addit
region
make
mhc
class
ii
gene
adjac
region
contain
gene
code
protein
regul
immun
respons
immun
respons
ir
gene
call
irga
irgl
irgt
human
histocompat
complex
dog
inherit
block
one
block
haplotyp
sire
one
dam
two
sibl
possess
serolog
dna
sequenc
defin
dla
antigen
one
loci
also
possess
ident
haplotyp
greatest
similar
donor
recipi
tissu
therefor
occur
dlaident
sibl
least
identifi
occur
dladiffer
unrel
dog
firstset
reject
immun
respons
direct
graft
previous
unsensit
individu
usual
occur
period
day
histocompat
differ
great
take
sever
week
histocompat
differ
weak
begin
soon
graft
vascular
donor
donor
lymphocyt
present
graft
time
donat
graft
endothelium
express
signific
surfac
concentr
histocompat
antigen
donor
passeng
lymphocyt
contain
highest
level
alloantigen
surfac
normal
rest
donor
endothelium
much
lower
amount
recipi
tlymphocyt
survey
tissu
rapidli
detect
differ
bind
surfac
cell
type
follow
essenti
delay
type
hypersensit
reaction
target
donor
lymphocyt
passeng
lymphocyt
graft
endothelium
latter
tissu
essenti
target
respons
although
passeng
lymphocyt
may
play
import
primari
sensit
role
activ
lymphocyt
specif
alloantigen
graft
began
bind
low
number
graft
endothelium
releas
cytokin
one
effect
cytokin
caus
graft
endothelium
becom
activ
upregul
surfac
express
alloantigen
increas
surfac
alloantigen
express
make
graft
endothelium
much
vulner
attack
immun
lymphocyt
activ
tcell
bind
endothelium
mass
cytokin
releas
caus
eventu
death
endothelium
death
endothelium
thrombosi
occur
graft
die
rbc
antigen
may
also
present
graft
endothelium
act
target
reject
therefor
donor
recipi
alway
match
rbc
type
prior
graft
far
fewer
rbc
antigen
leukocyt
antigen
big
problem
leukocyt
match
toward
end
firstset
reject
antibodi
alloantigen
also
produc
antibodi
bind
endothelium
fix
complement
destruct
effect
graft
endothelium
allograft
place
individu
presensit
leukocyt
alloantigen
graft
reject
within
h
larg
antibodymedi
destruct
endothelium
process
known
second
set
acut
reject
blood
recipi
contain
high
level
cytotox
alloantibodi
addit
immun
lymphocyt
presensit
leukocyt
antigen
occur
previou
graft
previou
blood
transfus
pregnanc
secondset
reject
also
occur
graft
rbc
type
especi
recipi
natur
cytotox
antibodi
rbc
type
donor
whole
organ
allograft
uncommon
client
own
dog
routin
procedur
increasingli
done
experiment
individu
basi
sibl
dla
type
determin
serolog
dna
sequenc
success
engraft
minimum
antireject
treatment
howev
mismatch
transplant
vigor
reject
unless
intens
treat
certain
drug
signific
breakthrough
transplant
dog
may
come
discoveri
leflunomid
leflunomid
use
combin
prednison
cyclosporin
allow
longterm
mainten
graft
unrel
dog
first
time
lirtzman
et
al
pancreat
cell
transplant
success
done
dog
place
purifi
cell
small
semiperm
chamber
abdomen
chamber
allow
entranc
exit
solubl
nutrient
hormon
immun
cell
sever
review
applic
immunosuppress
therapi
dog
publish
miller
b
longer
date
newer
treatment
strategi
simpl
review
current
immunosuppress
therapi
provid
janeway
traver
treatment
immunolog
disord
direct
two
basic
area
caus
abnorm
immun
reaction
effect
abnorm
immun
reaction
instanc
treatment
food
allergi
hypoallergen
diet
would
direct
caus
steroid
therapi
without
chang
diet
would
direct
effect
type
mediat
inflamm
whenev
possibl
treatment
direct
caus
abnorm
immun
reaction
end
result
drug
use
treat
immunolog
diseas
often
call
immunosuppress
howev
technic
correct
say
drug
work
suppress
immun
respons
mani
case
ultim
mode
activ
one
immunomodul
immunoregul
perturb
immun
respons
modul
back
normal
balanc
immunosuppress
drug
use
develop
activ
mind
eg
glucocorticoid
cytotox
agent
gold
salt
rather
initi
use
decad
ago
antiinflammatori
steroid
gold
salt
antitumor
cell
cyclophosphamid
chlorambucil
azathioprin
vincristin
hormon
danazol
megesterol
acet
activ
howev
recent
explos
knowledg
interwork
immun
system
variou
lymphokin
cytokin
drug
specif
effect
immun
system
develop
cyclosporin
mycophenol
mofetil
tacrolimu
rapamycin
mizoribin
brequinar
leflunomid
ten
berg
schelleken
immunosuppress
drug
therapi
gener
effect
control
diseas
young
anim
age
anim
immun
disord
younger
anim
often
occur
face
rel
intact
even
hyperact
immun
system
immun
disord
older
anim
often
occur
degener
immun
system
intact
immun
system
amen
variou
modul
immun
system
defici
accessori
drug
drug
addit
steroid
withdrawn
diseas
complet
remiss
least
one
month
depend
long
took
achiev
remiss
period
glucocorticoid
dosag
also
increment
decreas
clinic
improv
occur
time
complet
remiss
diseas
occur
glucocorticoid
alreadi
reduc
mainten
level
sign
reappear
anim
receiv
glucocorticoid
alon
reestablish
remiss
combin
therapi
maintain
remiss
lowest
possibl
dosag
glucocorticoid
cytotox
drug
diseas
remain
remiss
least
two
three
month
steroid
alon
glucocorticoid
withdrawn
biggest
mistak
made
decreas
drug
dosag
rapidli
follow
rigid
time
schedul
treatment
long
steadi
albeit
slow
improv
seen
vigor
therapi
continu
decreas
level
discontinu
drug
follow
substanti
degre
improv
therapi
never
complet
discontinu
activ
diseas
present
even
though
appear
slight
almost
treatment
regimen
glucocorticoid
sole
treatment
agent
main
drug
combin
agent
glucocorticoid
strongli
synerg
antiinflammatori
andor
immunomodul
effect
number
agent
includ
cytotox
drug
gold
salt
even
specif
immunosuppress
like
cyclosporin
interestingli
nonsteroid
immunosuppress
drug
usual
work
nearli
well
glucocorticoid
sole
therapeut
agent
therefor
immunolog
diseas
respond
even
partial
high
dose
glucocorticoid
probabl
respond
well
combin
drug
therapi
convers
partial
respons
high
dose
glucocorticoid
usual
enhanc
synergist
respons
combin
therapi
combin
therapi
use
three
gener
circumst
partial
respons
steroid
therapi
alon
diseas
control
level
glucocorticoid
detriment
anim
health
desir
achiev
diseas
remiss
rapidli
sever
drug
use
combin
effect
dosag
drug
often
reduc
reduc
toxic
retain
even
enhanc
total
therapeut
efficaci
obviou
question
glucocorticoid
use
alon
combin
immunosuppress
therapi
initi
decis
base
familiar
veterinarian
use
drug
hisher
experi
treat
number
actual
case
diseas
question
mani
veterinarian
howev
reli
high
dosag
glucocorticoid
control
condit
effect
safe
treat
combin
therapi
veterinarian
also
will
accept
partial
control
diseas
use
steroid
alon
even
though
better
control
could
achiev
combin
therapi
prednison
prednisolon
dexamethason
commonli
use
glucocorticoid
combin
immunosuppress
drug
therapi
main
differ
among
glucocorticoid
rel
potenc
dexamethoson
around
seven
time
potent
per
mg
prednison
prednisolon
prednison
metabol
prednisolon
bodi
latter
activ
moieti
therefor
might
advantag
give
prednisolon
prednison
especi
liver
problem
realiti
two
drug
use
interchang
glucocorticoid
exert
immunosuppress
effect
variou
way
glucocorticoid
highli
suppress
normal
primari
secondari
antibodi
respons
therapeut
dosag
although
seem
markedli
depress
abnorm
autoantibodi
format
ie
coomb
antibodi
antiplatelet
antibodi
antinuclear
antibodi
regard
appear
favor
regul
effect
event
lead
abnorm
antibodi
product
glucocorticoid
caus
pronounc
lymphopenia
limit
number
cell
avail
particip
cellmedi
process
glucocorticoid
may
reduc
specif
antigeninduc
blastogenesi
lymphocyt
drug
produc
monocytosi
diminish
respons
cell
inflammatori
mediat
monocyt
function
vitro
vivo
decreas
effect
manifest
system
decreas
uptak
opson
nonopson
materi
reticuloendotheli
system
local
decreas
influx
monocyt
inflammatori
site
reticuloendotheli
blockad
effect
obviou
benefit
control
red
cell
thrombocyt
destruct
autoimmun
hemolyt
anemia
thrombocytopenia
glucocorticoid
inhibit
product
interferon
affect
neutrophil
function
increas
blood
neutrophil
level
stimul
releas
marrow
paradox
glucocorticoid
inhibit
migrat
neutrophil
blood
inflammatori
site
also
impair
neutrophil
chemotaxi
adhes
bacteri
kill
lysosom
enzym
secret
vivo
glucocorticoid
greatli
reduc
number
circul
eosinophil
sever
miscellan
effect
glucocorticoid
may
benefit
treatment
immunolog
diseas
glucocorticoid
appear
depress
serum
complement
level
also
interfer
passag
immun
complex
basement
membran
effect
obviou
benefit
treatment
immun
complexmedi
disord
corticosteroid
use
highest
dosag
level
first
week
control
diseas
decreas
dosag
slowli
stepwis
week
interv
long
continu
signific
improv
improv
gaug
measur
paramet
rbc
number
platelet
number
joint
fluid
cytolog
etc
outward
sign
health
initi
dosag
exceed
mgkg
po
per
day
except
small
dog
cat
dosag
may
greater
give
initi
high
level
benefici
administ
drug
divid
daili
dose
clinic
sign
disappear
glucocorticoid
level
decreas
sever
week
mainten
level
mainten
level
prednison
prednisolon
mgkg
po
everi
day
lower
possibl
discontinu
glucocorticoid
therapi
least
one
three
month
diseas
remiss
longer
take
achiev
remiss
longer
anim
maintain
remiss
drug
discontinu
soon
diseas
like
recur
diseasefre
interv
often
shorter
glucocorticoid
often
use
conjunct
one
number
differ
cytotox
drug
term
cytotox
drug
refer
drug
abil
kill
cancer
cell
initi
develop
cytotox
drug
also
potent
effect
immun
system
often
antiinflammatori
well
cytotox
immunosuppress
drug
use
veterinari
medicin
belong
three
basic
group
alkyl
agent
thiopurin
vinca
alkaloid
folic
acid
antagonist
methotrex
compos
fourth
group
methotrex
howev
toxic
consid
routin
use
alkyl
agent
found
among
potent
immunosuppress
drug
avail
alkyl
agent
work
cross
link
dna
divid
rest
cell
also
alkyl
nucleic
acid
alkyl
guanin
pair
thymin
instead
cytosin
thu
caus
misread
genet
code
produc
effect
therefor
interf
cell
divis
cyclophosphamid
cytoxan
chlorambucil
leukeran
potent
immunosuppress
agent
group
alkyl
agent
act
mani
arm
immun
respons
inhibit
normal
primari
secondari
respons
well
delay
hypersensit
reaction
prolong
surviv
organ
graft
decreas
product
interferon
diminish
antigen
trap
lymph
node
inhibit
local
inflammatori
respons
alkyl
agent
act
lymphoid
cell
kill
slowli
prolifer
antigen
reactiv
cell
well
rapidli
prolifer
specif
stimul
cell
inhibit
antibodi
synthesi
h
week
antigen
administr
cyclophosphamid
popular
alkyl
agent
usual
given
dosag
base
bodi
surfac
area
rather
bodi
weight
also
true
cytotox
drug
discuss
later
larger
dog
requir
less
drug
per
kilogram
bodi
weight
small
dog
cat
cyclophosphamid
given
dosag
mgkg
po
daili
dog
kg
mgkg
po
daili
dog
kg
mgkg
po
daili
dog
kg
cat
cyclophosphamid
given
daili
four
consecut
day
week
follow
three
day
drug
refer
one
cycl
therapi
cyclophosphamid
also
given
previous
mention
dosag
alternateday
basi
chlorambucil
much
less
util
cyclophosphamid
treatment
immunolog
diseas
human
effect
treatment
number
glomerulonephritid
lupu
nephriti
idiopath
nephrot
syndrom
children
diseas
human
chlorambucil
shown
much
effect
cyclophosphamid
fewer
side
effect
impress
anim
less
effect
cyclophosphamid
immunosuppress
agent
decreas
efficaci
compens
lesser
toxic
drug
probabl
see
increas
usag
veterinari
medicin
treatment
immunolog
diseas
clinician
learn
use
treat
condit
chlorambucil
given
dosag
kg
mgkg
po
daili
anim
weight
rang
smaller
dog
receiv
mgkg
larger
dog
mgkg
po
daili
remiss
achiev
drug
administ
previous
mention
dosag
everi
day
cyclophosphamid
chlorambucil
sever
potenti
side
effect
prescrib
dosag
bone
marrow
suppress
anim
reason
blood
count
done
everi
two
week
first
two
month
therapi
monthli
bimonthli
thereaft
white
blood
cell
count
allow
go
lower
occur
drug
briefli
discontinu
reinstitut
threefourth
origin
dose
steril
hemorrhag
cystiti
common
side
effect
chronic
cyclophosphamid
therapi
reason
cyclophosphamid
use
period
longer
three
four
month
cytotox
drug
therapi
requir
period
time
chlorambucil
azathioprin
substitut
cyclophosphamid
neither
drug
induc
steril
hemorrhag
cystiti
cyclophosphamid
chlorambucil
retard
new
hair
growth
shave
area
thiopurin
achiev
effect
compet
adenin
synthesi
nucleic
acid
net
result
substitut
nucleic
acid
nonsens
base
inoper
nucleic
acid
strand
thiopurin
therefor
prevent
prolifer
rapidli
divid
cell
popul
differ
effect
cyclophosphamid
work
rest
slowli
divid
cell
well
azathioprin
imuran
purinethol
wide
use
thiopurin
compound
azathioprin
cleav
bodi
two
molecul
activ
moieti
two
drug
therefor
use
interchang
thiopurin
strongli
inhibit
tlymphocyterel
function
cellmedi
immun
tlymphocytedepend
antibodi
synthesi
optimum
effect
must
given
stage
immun
respons
cell
rapidli
divid
thiopurin
use
prevent
allograft
reject
particularli
strong
inhibitori
effect
express
delay
hypersensit
also
potent
inhibitori
effect
nonspecif
inflammatori
respons
may
due
part
inhibit
influx
mononuclear
cell
site
thiopurin
potent
inhibitor
primari
humor
antibodi
respons
inhibit
secondari
antibodi
respons
requir
higher
level
drug
thiopurin
use
success
treat
mani
autoimmun
disord
human
drug
benefici
treatment
autoimmun
hemolyt
anemia
pure
red
cell
aplasia
crohn
diseas
pemphigu
vulgari
system
lupu
erythematosu
lupoid
hepat
chronic
activ
liver
diseas
goodpastur
syndrom
allerg
vascul
wegen
granulomatosi
polyneur
rheumatoid
arthriti
thiopurin
use
number
diseas
dog
immun
cytopenia
idiopath
polyarthr
system
lupu
erythematosu
bullou
dermatitid
dosag
azathioprin
mgkg
po
daili
diseas
control
alternateday
therapi
use
dosag
previous
mention
alternateday
therapi
glucocorticoid
thiopurin
given
consecut
day
use
recommend
dosag
azathioprin
safe
drug
potenti
bone
marrow
suppress
rinkardt
kruth
gastrointestin
toxic
higher
level
use
cytotox
drug
recommend
white
blood
cell
count
monitor
everi
week
first
week
therapi
allow
fall
white
cell
count
fall
level
drug
discontinu
week
reinstitut
dosag
like
alkyl
agent
thiopurin
retard
hair
growth
vinca
alkaloid
use
treatment
certain
cancer
anim
human
vincristin
oncovin
wide
use
drug
group
vincristin
inhibit
format
cytoplasm
microtubular
network
prevent
cell
divis
interf
format
mitot
spindl
phagocytosi
also
involv
cytoplasm
endoskeleton
also
effect
vinca
alkaloid
report
immunosuppress
effect
drug
cyclophosphamid
potent
immunosuppress
effect
nearli
toxic
level
sole
use
vincristin
immunolog
disord
treatment
autoimmun
thrombocytopenia
human
anim
addit
effect
phagocytosi
abnorm
platelet
drug
curiou
thrombocytot
properti
actual
increas
product
platelet
dosag
vincristin
dog
mgkg
iv
week
go
effect
dramat
rise
platelet
count
occur
within
four
six
day
first
inject
sever
day
second
inject
therapi
discontinu
respons
seen
second
dose
vincristin
recommend
use
case
thrombocytopenia
three
situat
anim
sever
blood
loss
vincristin
often
give
much
rapid
respons
prednison
prednisolon
alon
anim
poor
neglig
respons
glucocorticoid
anim
fail
respond
glucocorticoid
splenectomi
vincristin
splenectomi
appar
addit
effect
even
respons
occur
splenectomi
alon
case
thrombocytopenia
immun
origin
respond
well
glucocorticoid
alon
requir
vincristin
therapi
even
vincristin
use
combin
glucocorticoid
therapi
facilit
maintain
remiss
achiev
sideeffect
gener
less
cytotox
drug
especi
limit
one
two
dose
sideeffect
includ
sever
perivascular
reaction
inject
vein
leukopenia
nadir
day
inject
peripher
neuropathi
gold
oldest
immunosuppress
drug
first
use
koch
treatment
tuberculosi
later
use
success
treatment
sle
ra
thought
one
time
form
tuberculosi
gold
avail
aurothioglucos
solganol
schere
gold
sodium
thiomal
mycochrysin
merck
aurothioglucos
less
acut
anaphylact
reaction
drug
choic
avail
suspens
contain
mgml
gold
dosag
dog
mgkg
im
everi
week
six
eight
week
mgkg
month
gold
excret
bodi
urin
fece
administ
dose
excret
week
level
gold
bodi
progress
increas
therefor
weekli
dose
gold
level
maintain
thereaft
monthli
inject
residu
gold
still
found
year
therapi
ceas
precis
mode
action
gold
salt
unknown
maximum
therapeut
effect
often
take
six
eight
week
obtain
gold
stabil
lysosom
enzym
inhibit
certain
leukocyt
enzym
system
decreas
migrat
phagocyt
cell
site
inflamm
diminish
phagocyt
activ
inactiv
complement
compon
inhibit
prostaglandin
synthesi
inhibit
antigen
mitogen
induc
lymphocyt
prolifer
suppress
immunoglobulin
synthesi
stabil
collagen
also
found
decreas
immunoglobulin
level
rheumatoid
factor
level
autoantibodi
level
pemphigu
foliac
chrysotherapi
use
adjuv
glucocorticoid
drug
therapi
seldom
effect
sole
immunosuppress
agent
howev
reduc
effect
therapeut
dose
corticosteroid
way
reduc
cortison
sideeffect
gold
take
mani
week
reach
maximum
level
efficaci
often
combin
initi
glucocorticoid
cytotox
drug
time
remiss
achiev
gold
start
take
effect
remiss
achiev
cytotox
drug
withdrawn
attempt
made
maintain
remiss
glucocorticoid
gold
salt
alon
remiss
sustain
dosag
glucocorticoid
slowli
reduc
case
withdrawn
addit
gold
therapi
fail
provid
signific
benefit
six
week
weekli
treatment
drug
discontinu
six
week
good
respons
note
gold
treatment
continu
monthli
basi
chrysotherapi
use
treat
bullou
diseas
idiopath
polyarthr
vascul
rheumatoid
arthriti
dog
man
use
gold
salt
counterind
treatment
sle
dog
sle
howev
seem
respond
favor
gold
therapi
less
dog
chronic
chrysotherapi
develop
thrombocytopenia
aplast
anemia
toxic
nephriti
oral
ulcer
stomat
epiderm
necrolysi
except
nephriti
sideeffect
usual
clear
drug
withdrawn
recoveri
take
sever
week
month
howev
addit
sideeffect
man
includ
dermat
proteinuria
gi
upset
neurolog
reaction
hepatopathi
acut
anaphylact
reaction
cyclosporin
avail
inject
iv
incorpor
oliv
oil
use
eye
drop
cyclosporin
readili
absorb
blood
conjunctiv
sac
canin
dosag
mgkg
iv
q
h
sever
day
establish
blood
level
mgkg
po
q
h
thereaft
blood
level
achiev
oral
administr
vari
greatli
depend
individu
therefor
adjust
oral
dosag
achiev
trough
taken
prior
second
date
whole
blood
level
ngml
cyclosporin
first
new
gener
immunosuppress
drug
rel
specif
mode
action
cyclosporin
caus
tcell
remain
rest
phase
respons
activ
signal
work
specif
thelpercytotox
cell
tcell
spare
tsuppressor
cell
tcell
cyclosporin
interact
cyclophillin
block
tcell
signal
transduct
activ
increas
product
macrophag
tcell
cyclosporin
also
inhibit
bcell
growth
factor
inhibit
cidal
activ
macrophas
respons
g
interferon
cyclosporin
use
combin
prednison
effect
treatment
autoimmun
disord
iha
itp
cyclosporin
also
appear
hold
promis
treatment
bullou
diseas
man
anim
cyclosporin
eye
drop
prove
effect
onehalf
case
kerat
sicca
dog
drug
highli
synergist
glucocorticoid
combin
therapi
minim
toxic
drug
provid
maxim
therapeut
benefit
cyclosporin
therapi
especi
larger
dog
current
expens
oral
administr
ketaconazol
use
reduc
substanti
oral
dose
cyclosporin
need
maintain
effect
blood
level
dahling
et
al
total
cost
save
ca
leflunomid
develop
origin
antiinflammatori
drug
found
far
activ
wide
rang
immun
disord
murin
model
model
includ
asthma
sle
chronic
graft
versu
host
diseas
autoimmun
tubulointerstiti
nephriti
antibas
membran
glomerulonephr
allerg
encephalomyel
autoimmun
uveiti
antiallograft
antixenograft
reject
eber
et
al
waer
wennberg
et
al
xu
et
al
yeh
et
al
yeh
et
al
drug
significantli
decreas
diseasespecif
antibodi
format
leflunomid
also
shown
great
promis
treatment
rheumatoid
arthriti
peopl
mladenov
et
al
rozman
undergo
trial
sle
strand
leflunomid
antiprolif
effect
tcell
depend
independ
antibodi
synthesi
silva
jaunior
morri
drug
effect
releas
cytokin
antagon
action
gcsf
gmcsf
tnf
cao
et
al
effect
ifng
recent
leflunomid
shown
inhibit
pyrimidin
synthesi
inhibit
revers
free
uridin
fox
zielinski
et
al
leflunomid
also
inhibit
cytokineand
growth
factor
receptormedi
tyrosin
kinas
activ
silva
jaunior
morri
xu
et
al
leflunomid
mani
potenti
use
veterinari
medicin
use
prednison
cyclosporin
virtual
elimin
allograft
reject
respons
made
possibl
transplant
dog
notori
violenc
reject
respons
even
prednison
cyclosporin
treatment
lirtzman
et
al
leflunomid
also
shown
great
promis
treatment
immun
diseas
dog
one
metabolit
leflunomid
trifluromethylanilin
tfma
highli
gastroenterotox
dog
therefor
dose
dosag
regimen
must
close
follow
drug
teratogen
rat
longterm
use
may
lead
increas
certain
neoplasm
dose
dog
mgkgday
per
os
serum
trough
level
ugml
achiev
danazol
nonviril
androgen
use
treatment
refractori
immunemedi
hematolog
disord
sle
man
cervera
et
al
danazol
thought
work
decreas
densiti
fc
receptor
macrophag
fc
receptor
bind
fc
portion
platelet
bound
immunoglobulin
facilit
macrophagemedi
destruct
antibodi
coat
platelet
human
case
immunemedi
thrombocytopenia
refractori
standard
therapi
respond
danazol
within
week
advoc
use
dog
purpos
miller
also
use
treat
dog
evanslik
syndrom
holloway
et
al
danazol
come
oral
tablet
dosag
mgkg
po
daili
least
eight
week
respons
eight
week
discontinu
use
prove
effect
treat
month
tri
take
drug
reduc
dosag
notic
sideeffect
associ
use
dog
although
highli
tout
first
report
effect
human
dog
met
expect
intraven
administr
g
globulin
therapeut
benefit
peopl
iha
itp
well
immun
disord
one
studi
human
g
globulin
given
intraven
shown
provid
shortterm
benefit
given
dog
iha
improv
longterm
surviv
scottmoncrieff
human
immun
globulin
also
given
dog
iha
fail
respond
glucocorticoid
seven
day
addit
globulin
appear
benefici
anim
kellerman
bruyett
studi
need
done
use
canin
rather
human
gamma
globulin
splenectomi
commonli
use
adult
form
itp
human
case
iha
consid
treatment
last
resort
anim
howev
use
limit
follow
situat
satisfactori
remiss
obtain
singl
combin
drug
therapi
alon
anim
show
toxic
chronic
drug
therapi
need
maintain
remiss
either
drug
need
elimin
altogeth
dosag
need
decreas
mix
result
describ
splenectomi
dog
one
studi
iha
itp
evan
syndrom
splenectomi
found
reduc
elimin
need
immunosuppress
drug
dog
feldman
et
al
anoth
studi
dog
itp
dog
relaps
hard
medic
control
diseas
abl
go
drug
splenectomi
jan
et
al
